Exploratory study of mindfulness for inpatients with chronic gastrointestinal pain: does it reduce pain related distress and increase confidence in pain self-management? by Ellis, R
  
 
 
Exploratory study of mindfulness for inpatients with 
chronic gastrointestinal pain: does it reduce pain related 
distress and increase confidence in pain self-management? 
 
 
Rebecca Ellis 
 
 
 
D.Clin.Psy. thesis (Volume 1) 
2015 
 
 
 
University College London 
  
2 
UCL Doctorate in Clinical Psychology 
 
Thesis declaration form 
 
 
 
 
I confirm that the work presented in this thesis is my own. Where information has 
been derived from other sources, I confirm that this has been indicated in the thesis. 
 
 
 
Signature: 
 
Name: Rebecca Ellis 
 
Date: 18/06/2015 
 
 
  
3 
Overview 
 
Part 1: Literature review.  A systematic review of seven randomised controlled 
trials that examined the efficacy of mindfulness-based interventions for Irritable 
Bowel Syndrome. The aim was to replicate an existing meta-analysis, critically 
evaluate design and theoretical issues raised by the studies and discuss 
recommendations for future research.  
Part 2: Empirical paper. A mixed methods study evaluated the use of a guided 
self-help mindfulness course (using a book and audio guided meditations based on 
MBSR) with 15 inpatients with gastrointestinal pain. Change in pain distress and 
intensity were quantitatively assessed at multiple time points and graphically 
analysed. Change in psychological distress, self-efficacy, pain acceptance and 
mindfulness skills were quantitatively assessed at baseline and endpoint and 
analysed for reliable and clinically significant change. Interviews were used to 
qualitatively explore the usefulness and applicability of the mindfulness course with 
this patient group. Pain distress reduced over the duration of the course and 
improvements in quality of life reported. For those able to complete, the course was 
experienced as straightforward and useful, even when experiencing intense pain. 
Significant challenges and barriers to completing the course were experienced by 
many participants mostly related to the disruption of living with chronic pain and 
illness. 
Part 3: Critical appraisal.  Reflections on the process of conducting the empirical 
study are discussed. 
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Abstract 
Background.  Irritable Bowel Syndrome (IBS) is a common disorder characterised 
by abdominal pain and alteration of bowel habits and is defined by an absence of 
structural or anatomical abnormality. Current explanations emphasise the importance 
of psychological processing and dysfunction of the brain-gut axis. Psychological 
interventions including CBT and psychotherapy have shown some benefits for 
individuals with IBS. Mindfulness has been hypothesised as an appropriate avenue 
for research due to its applicability to the function of the brain-gut axis.  
Aims. To review published accounts of randomised controlled trials of mindfulness-
based therapies for IBS against questions of theoretical and design issues. 
Method. A systematic search of Pubmed, EBSCO, Cochrane, PsychINFO, AMED, 
Medline, and Embase was undertaken. Nine papers describing seven randomised 
controlled trials were included. 
Results. A previous meta-analysis including eight of the nine papers found that 
mindfulness-based interventions were effective at reducing symptom severity 
(d=0.59, 95% CI 0.33 to 0.86) and improving quality of life (d=0.56, 95% CI 0.34 to 
0.79) in IBS (Aucoin, Lalonde-Parsi & Cooley, 2014). The study findings are then 
discussed alongside theoretical and design issues. 
Conclusions. Tentative recommendations are made for wider availability of 
mindfulness-based interventions for IBS patients, focussing on patients who wish to 
explore a psychological model of coping with IBS. More research is needed on the 
importance of between-session practice and specific mindfulness techniques. 
Recommendations are also made to further investigate the role of non-specific 
placebo effects in the effective management of IBS.  
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Introduction 
IBS 
Definition. Irritable Bowel Syndrome (IBS) is a functional gastrointestinal 
(GI) disorder for which there is no known structural or anatomical explanation. It 
differs from Irritable Bowel Disease (IBD) where structural and anatomical 
malformations are apparent such as in Ulcerative Colitis or Crohn’s Disease. 
Symptoms. Symptoms of IBS include abdominal pain or discomfort, altered 
bowel habits (diarrhoea and/or constipation), and bloating (Longstreth et al., 2006). 
Symptoms are usually not stable but occur over a chronic relapsing-remitting course. 
Several different diagnostic criteria exist for IBS and the most commonly used in 
clinics and research is the Rome III criteria (Drossman, 2006).  These criteria specify 
that abdominal pain or discomfort must occur on at least three days each month and 
be associated with changes in frequency or form of stool, with onset of symptoms a 
minimum of six months prior to diagnosis. 
Prevalence. Prevalence estimates vary between 2% and 17% in the general 
population (Hungin, Whorwell, Tack, & Mearin, 2003; Mearin et al., 2001) 
depending on the diagnostic criteria used, but many individuals do not receive a 
formal diagnosis. It is more common in women than men (Spiller et al., 2007). 
Comorbidity. Patients with IBS often also meet diagnostic criteria for Axis I 
mood disorders such as depression and anxiety at rates of between 40% and 94 %  
(Whitehead, Palsson, & Jones, 2002) and at a prevalence rates higher than that for 
general medical patients or patients with a diagnosis of IBD (Palsson & Drossman, 
2005). Higher rates of comorbidity are seen in patients attending tertiary care than in 
community samples. Stressful life events often precede onset of symptoms and 
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patients report that stress exacerbates their IBS symptoms (Palsson & Drossman, 
2005). 
Impact. Although IBS has a benign prognosis, the symptoms can have a 
serious impact on health-related quality of life (Chang, 2004), often resulting in 
greater impairment than in similar diseases with an identifiable organic basis. 
Compared to the general US population, patients with IBS reported significantly 
worse health-related quality of life in all eight domains (physical functioning, 
physical role limitations, bodily pain, emotional wellbeing, emotional role 
limitations, energy/fatigue, social functioning and general health) on the SF-36 
health-related quality of life measure. In addition, except for the physical functioning 
subscale, IBS patients reported significantly worse health-related quality of life on 
all subscales compared to patients with gastroesophageal reflux disease (GERD) , 
and worse energy/fatigue, bodily pain, emotional wellbeing and social functioning 
than patients with end-stage renal disease (Gralnek, Hays, Kilbourne, Naliboff, & 
Mayer, 2000).  
Qualitative research has similarly emphasised the extent of the impact of IBS 
on individuals including extensive impact on daily living, emotional well-being and 
self-identity (Farndale & Roberts, 2011). A systematic review of the qualitative 
literature focussing on the impact IBS has on the lives of adults who are diagnosed 
with it concluded that “living with IBS…colors the person’s whole existence” 
(Håkanson, 2014, p.223) with limitations including being unable to move about 
freely, fulfil commitments at work, maintain social activities, uphold or develop 
close and/or sexual relationships or to live a life spontaneously. Other themes to 
emerge from the qualitative literature on the impact on IBS on individuals include 
feelings of shame from the embarrassing nature of symptoms, and feeling unable to 
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trust their bodies (Håkanson, 2014; Jakobsson, Ringstrom, Sjövall, & Simrén, 2013; 
Rønnevig, Vandvik, & Bergbom, 2009). Patients with long-term experience of living 
with IBS described overall improvement over time, but of living chronically in 
intermittent states of well-being and illness, and of eventually finding effective 
strategies for their bodies (Jakobsson et al., 2013). 
Biopsychosocial model of IBS 
The biopsychosocial model of illness and disease was proposed by Engel 
(1977) as an alternative to the predominant biomedical model. Although no explicit 
biomedical model was ever proposed, it is conceptualised as modelling health and 
illness according to identifiable organic factors. The biomedical model is a useful 
way to conceptualise many diseases and their treatments, but it lacks a specific focus 
on psychological and social factors. In contrast the biopsychosocial model proposes 
that psychological and social factors reciprocally influence biological disease 
processes. 
IBS has been conceptualised within a biopsychosocial model (Drossman, 
1998) with psychological and social stressors being reciprocally linked with 
biological changes to gut motility and visceral sensitivity. These reciprocal 
relationships are best explained by reference to the brain-gut axis. 
Brain-gut axis 
The brain-gut axis describes a continuous feedback loop between enteric 
nervous system (ENS) sensory neurons in the intestines, colon and rectum (which 
together form the gastrointestinal tract) and motor responses generated in the central 
nervous system (CNS) (Burnett  & Drossman, 2004). Gastrointestinal nerve signals 
are carried along the autonomic nervous system and rarely enter conscious 
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perception in a healthy individual. They also do not convey information about touch 
and temperature, but about distension, torsion, and similar effects.   
In healthy gastrointestinal functioning, the links between CNS processing 
(such as emotions) and gastrointestinal sensory and motor functions are familiar in 
everyday life. For example, stress, anxiety and worry are often accompanied by 
abdominal symptoms such as the sensation of ‘butterflies in the stomach’, abdominal 
pain or an urge to go to the toilet (Mönnikes et al., 2001). In certain individuals 
however, changes to the brain-gut axis leads to hypersensitivity, and visceral signals 
from the gut (which would not usually be consciously perceived), are experienced as 
discomfort or pain. This can result in many different clinical presentations, one of 
which is IBS where pain and discomfort are experienced in relation to altered 
gastrointestinal function (Mayer & Tillisch, 2011). Neural changes of the CNS can 
be observed in patients with IBS using functional magnetic resonance imaging 
(fMRI). Differences of activation in regions associated with emotional arousal 
(pregenual anterior cingulate cortex, amygdala) and regions involved with 
endogenous pain modulation have been shown following rectal balloon distension 
(Tillisch, Mayer, & Labus, 2011). It is suggested that the symptoms of IBS continue 
to occur due to structural changes in the brain, spinal cord and gut (Seminowicz et 
al., 2010). 
Psychological interventions for IBS 
As psychological factors are an important component of the biopsychosocial 
model of IBS, psychological interventions have the potential to impact on 
individuals’ experience of symptoms. 
As a group, psychological treatments have been shown to have a small but 
consistent impact on reduction of IBS symptoms (Drossman, 1999; Ford, Talley, 
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Schoenfeld, Quigley, & Moayyedi, 2009; Pajak, Lackner, & Kamboj, 2013). 
Psychological treatments have also been found to be equally effective as 
antidepressants in reducing the number of participants with persistent IBS symptoms 
following treatment (relative risk of 0.67 and 0.66 respectively) (Ford et al., 2009). 
Cognitive behaviour therapy (CBT), hypnosis and psychodynamic interpersonal 
therapy have been shown to be effective in reducing abdominal pain, bowel 
dysfunction, depression and anxiety in different subsets of patients with IBS (Spiller 
et al., 2007). 
CBT. CBT for IBS includes changing IBS-related behaviours such as 
avoidance of situations thought to trigger symptoms (for example restrictions of 
certain foods, avoiding lengthy durations away from home or going far from known 
toilet locations) which become unhelpful as they can increase gastro-specific anxiety 
and maintain/worsen symptoms. This is done by using graded exposure and working 
towards valued goals such as attending specific social events, or maintaining 
physical activity. It also includes challenging cognitions and beliefs about IBS and 
ways of processing internal and external information about symptoms, such as 
catastrophising, worry and depressive thinking. Patients with IBS who believed that 
their symptoms were associated with serious pathology reported more intense 
symptoms and used fewer adaptive coping strategies (Drossman et al., 1999). 
Evidence for the efficacy of CBT in reducing IBS symptoms and improving quality 
of life is mixed and meta-analyses have shown small but positive improvements 
following CBT interventions (Zijdenbos, de Wit, van der Heijden, Rubin, & 
Quartero, 2009). 
Hypnosis. Clinical hypnosis is the second most commonly researched 
therapy for IBS. Hypnosis induces an altered mental state of heightened receptivity 
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and uses therapeutic imagery and verbal suggestions to influence both mental and 
physiological changes. When used with IBS patients hypnotherapy aims to produce 
physical relaxation, especially of the gastrointestinal region, reduce attention to 
sensations of discomfort from the intestines, reduce perception of threat and enhance 
perception of control over symptoms (Palsson & Drossman, 2005). Studies have 
shown a reduction in unhelpful IBS-related cognitions, affective symptoms and an 
improvement of gastrointestinal symptoms following hypnosis (Palsson, Turner, 
Johnson, Burnett, & Whitehead, 2002). A Cochrane review was unable to conclude 
on the efficacy of hypnotherapy for IBS as only four trials met inclusion criteria for 
the review and all were of low methodological quality, but findings from the 
individual studies showed positive effects on abdominal pain and IBS symptoms in 
patients who did not respond to standard medical therapy (Webb, Kukuruzovic, 
Catto-Smith, & Sawyer, 2008). 
Psychodynamic interpersonal therapy. The aim of psychodynamic 
interpersonal therapy for IBS is to enable the patient to gain insight into the context 
in which symptoms developed, such as changes in relationships or life stressors and 
it also aims to highlight the link between emotions and bowel symptoms (Spiller et 
al., 2007). Although studies of psychodynamic interpersonal therapy for IBS have 
had low methodological quality, small improvements have been shown on IBS 
symptoms (Zijdenbos et al., 2009).  
Guthrie and colleagues used a 12 week psychotherapy protocol for patients 
with chronic, refractory IBS. This involved an initial three hour session aimed at 
fostering a strong therapeutic alliance and then six further 45 minute sessions spread 
over the 12 weeks. Compared to an equal number of ‘supportive listening’ sessions, 
psychodynamic psychotherapy led to significant improvements on both 
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psychological and physical symptoms, analysis suggested that the improvement in 
bowel symptoms was mediated by the improvement in psychological factors 
(Guthrie, Creed, Dawson, & Tomenson, 1993). Using the same psychotherapy 
protocol but comparing to treatment with a selective serotonin reuptake inhibitor 
(SSRI) antidepressant or treatment as usual (TAU), no significant changes in 
abdominal pain were observed, but both the psychotherapy and SSRI groups showed 
significant improvement in health-related quality of life (Creed et al., 2003). Out of 
the 257 patients recruited to that study, 107 met criteria for a concurrent psychiatric 
disorder. Although improvements on the psychiatric domains were correlated with 
improvements in health-related quality of life, they could not account for all of it 
(Creed et al., 2005). 
Relaxation training. Relaxation training uses techniques such as progressive 
muscular relaxation, meditation and biofeedback to help patients reduce physical 
tension. It is often used as a component in other psychological interventions such as 
CBT and when studied as an intervention on its own, effects have been positive but 
small and unreliable (Zijdenbos et al., 2009). Progressive muscular relaxation 
focuses on skeletal muscle as opposed to the viscera and so any improvement in IBS 
symptoms would be related to the effect of general relaxation of the whole body, 
rather than specific effects on the gut. 
Mindfulness 
More recently, attention has turned towards the potential benefits of 
mindfulness-based therapies with IBS patients. Mindfulness can be described as 
bringing one’s attention to present moment experiences in an open, curious and 
accepting manner, without immediately attaching value judgements such as good or 
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bad (Kabat-Zinn, 1990). It has been conceptualised as a capacity inherent in all 
humans, but which varies within and between individuals (Brown & Ryan, 2003).  
History 
The practices of mindfulness have been in use in Eastern traditions for over 
2500 years and developed within Buddhist traditions. In the 1970s, the principles of 
non-judgemental, present-moment awareness and meditation began to be used more 
widely in Western cultures. The first structured programme to use mindfulness was 
developed by Jon Kabat-Zinn in the USA for use with patients with chronic pain and 
physical health problems (Kabat-Zinn, Lipworth, & Burney, 1985). A second 
widespread structured mindfulness programme was later developed by Mark 
Williams and others in the UK for recovered recurrently depressed patients to 
prevent depressive relapse (Segal, Williams, & Teasdale, 2002). 
Mindfulness-Based Stress Reduction (MBSR). Kabat-Zinn developed 
MBSR as an eight week group programme for chronically ill people to cope more 
effectively with their distress (Kabat-Zinn, Lipworth, Burney, & Sellers, 1986). The 
intensive course involves two and a half hours instructed mindfulness practise per 
week, a seven hour mindfulness retreat halfway, and consistent daily practice of 
meditation at home for at least 45 minutes a day. 
MBSR is made up of three different techniques. The ‘body scan’ involves 
sequentially turning attention to each part of body, focusing uncritically on any 
sensation or feeling in the body as it is experienced and using awareness of the 
breath and relaxation. The ‘sitting meditation’ involves paying attention to the breath 
or on the movement of the abdomen, as well as on other perceptions. It also 
encourages awareness of the stream of thoughts and distractions that repeatedly enter 
the mind, but with a non-judgemental attitude. The third element is ‘hatha yoga’ 
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practice which includes straightforward stretches, breathing exercises, and 
development of posture designed to relax the muscles in the body and build strength. 
Mindfulness-Based Cognitive Therapy (MBCT). MBCT was developed by 
researchers at the University of Oxford (Segal et al., 2002). They combined aspects 
of mindfulness with elements from CBT aimed at preventing the recurrence of 
depression. MBCT was based on MBSR and shares many features. Several different 
meditations are introduced across the eight week group programme including ‘the 
body scan’, ‘mindful movement’ and different length ‘sitting meditations’.  
Acceptance and Commitment therapy (ACT). Mindfulness is also a 
component of ACT (Hayes, Strosahl, & Wilson, 1999). In contrast to CBT, where 
the focus might be to challenge unhelpful thoughts and behaviours in response to 
feelings, in ACT the aim is to accept and acknowledge difficult thoughts and 
sensations and instead to commit to actions that facilitate values-congruent living 
(Hayes et al., 1999). In this framework, mindfulness is used to increase contact with 
the present moment and encourages awareness and acceptance.  
Efficacy of mindfulness in pain and health conditions. Initial studies of 
MBSR comprised of patients with chronic pain from a variety of disorders 
(including musculoskeletal, neurological, gastrointestinal and cardiac pain).  
Findings from these studies reported significant improvements of pain ratings and 
physical symptoms (Kabat-Zinn et al., 1985), maintained at four year follow-up for 
improvement of physical and psychological symptoms (Kabat-Zinn et al., 1986).  
Meta-analyses have reported the efficacy of mindfulness-based therapies on 
reducing pain (Baer, 2003; Grossman, Niemann, Schmidt, & Walach, 2004; Reiner, 
Tibi, & Lipsitz, 2013). Another meta-analysis with more stringent measures of 
inclusion criteria reported a lack of evidence for specific effects of mindfulness on 
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pain reduction but strong evidence for non-specific effects, improvement of 
depressive symptoms and improvements in coping with pain (Chiesa & Serretti, 
2011). Mindfulness-based therapies have also been found to be effective in 
improving pain, physical symptoms and health-related quality of life in chronic 
fatigue syndrome and fibromyalgia (Lakhan & Schofield, 2013), cancer, coronary 
artery disease and obesity (Grossman et al., 2004). 
Efficacy of mindfulness with IBS. Mindfulness-based interventions may be 
particularly applicable in treating IBS symptoms as it could act on the brain-gut axis. 
As previously discussed, the brain-gut axis describes a reciprocal feedback loop 
between neurones in the gut and the brain. In cases such as IBS, over time the 
normal functioning of the gut and signalling along the brain-gut axis changes. 
Benign signals representing normal gastrointestinal functioning become processed as 
pain and discomfort in the brain. This in turn changes the descending signals from 
the brain, altering gastrointestinal functioning and leading to changes in bowel 
habits. Changes in brain regions related to pain processing have been shown to 
change after repeated mindfulness practice (Zeidan et al., 2011) in general pain 
conditions. It can therefore be expected that mindfulness will alter brain regions 
involved in the brain-gut axis related to the expression of IBS symptoms. This would 
be achieved through the practices of mindfulness encouraging awareness of physical 
sensations, in a non-judgmental way that uncouples the anxiety and fear related to 
symptoms. With repeated practice this could change signalling along the brain-gut 
axis towards ‘normal’ functioning (Garland et al., 2012). 
Two systematic reviews have reported effect sizes for the impact of 
mindfulness-based therapies on IBS symptom severity and quality of life. Lakhan 
and Schofield (2013) included three randomised controlled trials (RCTs) of 
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mindfulness-based therapies for IBS in a meta-analysis of twelve studies of 
mindfulness-based therapies for somatisation disorders1 (the other studies in the 
review focussed on fibromyalgia, chronic fatigue syndrome or mixed somatisation 
disorders). Small to moderate effects of mindfulness on pain, symptom severity, 
depression, anxiety and quality of life were reported, and the effects were most 
consistent for IBS, with none of the analysed outcomes showing deterioration in the 
IBS studies. Effect sizes for the three IBS studies were medium for improvement in 
symptom severity (0.70, 95% CI 0.44 to 0.96) and medium for quality of life (0.56, 
95% CI 0.31 to 0.82). 
Aucoin et al. (2014) performed a meta-analysis of mindfulness-based 
therapies in the treatment of functional gastrointestinal disorders (despite their search 
strategy allowing for inclusion of any FGID, only studies investigating IBS or IBS-
type symptoms were found). Six of the seven studies reported significant 
improvements in IBS symptom severity and quality of life following mindfulness-
based therapy. The one study which did not report an improvement in symptoms or 
quality of life recruited participants in remission of IBD and with either IBS 
symptoms or high perceived stress (and therefore would not have met official 
diagnostic criteria for IBS). However subgroup analysis of only those IBD patients 
with IBS-type symptoms (and not just high perceived stress levels) indicated that 
mindfulness was effective in reducing symptom severity (Berrill, Sadlier, Hood, & 
                                                          
1 The term somatisation disorders used in this context included any disorders 
“characterised by chronic, medically unexplained, treatment-resistant symptoms, 
combining psychological distress with chronic physical pain or discomfort” (p2, 
Lakhan & Schofield, 2013). This definition included IBS. However, this term will 
not be used to refer to IBS later in this review as it is an inclusive term defining 
many different syndromes, and the use of the term IBS better defines the population 
of interest in this review. 
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Green, 2014). Overall effect sizes were medium for improvement in symptom 
severity at post treatment (0.59, 95% CI 0.33 to 0.86) and medium for quality of life 
(0.56, 95% CI 0.47 to 0.79). 
Both systematic reviews inform researchers and clinicians about the efficacy 
of mindfulness-based therapies for IBS based on current published RCTs. They do 
not, however, review the components of the mindfulness-based therapies used in the 
studies, or assess the quality of the interventions (rather than the quality of the trial 
methodologies). Current evidence about mindfulness-based therapies needs to be 
reviewed to assess which components or quality criteria are essential and which are 
flexible whilst still providing positive patient outcomes. 
Aims of review 
This review aims to extend the findings from the Aucoin, et al. (2014) meta-
analysis of RCTs of mindfulness-based therapies for functional gastrointestinal 
disorders. Although their search criteria allowed for inclusion of any functional 
gastrointestinal disorder, only studies describing IBS or IBS-type symptoms were 
found.  This review focusses on IBS and not all functional gastrointestinal disorders 
as there is very little published evidence on FGIDs that are not IBS. The Aucoin et 
al. (2014) review was chosen over the Lakhan and Schofield (2013) review as it was 
more recent and focussed exclusively on IBS-type symptoms rather than 
somatisation disorders in general which would allow for discussion of the findings 
with reference to literature on the brain-gut axis. This review intends to look more 
closely at the interventions themselves and answer the following questions:  
1. What are the rationales for offering mindfulness-based therapies to 
individuals with IBS symptoms and how do the mindfulness based therapies 
chosen express these? 
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2. How do the study designs affect the generalisability of findings? 
3. What conceptual issues should inform future trial designs? 
Methods 
Systematic search strategy 
This review was based on the published search strategy of Aucoin et al. (2014). 
Their search incorporated three electronic databases (Pubmed, EBSCO, and 
Cochrane). This review extended the search to include four further databases 
(PsychINFO, AMED, Medline, and Embase) selected to ensure that no relevant 
papers were overlooked from psychological or alternative medicine journal sources. 
To identify papers examining mindfulness-based therapies, the following 
search terms were combined (mindfulness OR MBCT OR MBSR OR mindfulness-
based cognitive therapy OR mindfulness-based stress reduction OR mindful$), and 
to locate literature examining populations with functional gastrointestinal disorders, 
the following search terms were combined (functional gastrointestinal OR  
functional bowel OR colonic disease functional OR colonic disease OR functional 
abdominal pain OR IBS OR irritable bowel OR spastic colon OR irritable colon OR 
constipation OR diarrh$ OR bloating OR distention OR gastroesophageal reflux OR 
GERD OR dysphagia OR functional dyspepsia). These two terms were then 
combined with an AND function. The searches were limited to studies in humans 
from the earliest date available until October 2014.  
 
Results 
A total of 282 records were identified from the databases searched as shown 
in Table 1.  
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Table 1 
 
Search results 
  
Database 
 
Description of database 
 
N of 
studies 
Pubmed Contains biomedical literature, including all data from 
the National Center for Biotechnology Information 
(NCBI) at the US National Library of Medicine 
(NLM) 
48 
EBSCO Contains professional literature of nursing, allied 
health, biomedicine, and healthcare 
17 
Cochrane The Cochrane Library contains full-text information 
on the effects of interventions in health care 
41 
PsychINFO Contains literature in psychology and psychological 
aspects of related disciplines 
22 
AMED The Allied and Complementary Medicine Database 
contains references to articles on allied and alternative 
medicine. Many of the journals covered are not 
indexed by any other biomedical sources 
0 
Medline Contains journal articles from the National Library of 
Medicine. Covers medicine, nursing, dentistry, 
veterinary medicine, the health care system, and the 
preclinical sciences 
59 
EMBASE Comprehensive pharmacological and biomedical 
database renowned for extensive indexing of drug 
information 
95 
 
After duplicates were removed, 175 papers remained. The titles and abstracts 
of these 175 were read and papers excluded according to predetermined criteria as 
applied by Aucoin et al. (2014) and shown in Table 2. These exclusion criteria were: 
not describing a RCT of a mindfulness-based therapy (MBT) for use with a 
functional gastrointestinal disorder (FGID) population, an article reviewing findings 
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from other studies only, protocol only, participants aged <18, no measurement of 
FGID symptoms, combined with other types of pain, and no control group. 
Table 2 
Reasons for excluding studies based on titles and abstracts 
Exclusion criteria Number of studies excluded 
Not a RCT of MBT for FGID 137 
Review article 14 
Protocol only 4 
Paediatric sample 1 
FGID symptoms not measured 2 
Combined with other types of pain 1 
Lack of control 3 
 
Following screening of the titles and abstracts of the original 175 papers 
using the exclusion criteria stated, the remaining 13 full-text articles were retrieved 
and read and four were excluded as detailed in Table 3. 
 
Table 3 
Reasons for excluding studies based on full text 
Exclusion criteria Number of studies excluded 
Reported same results as another included study 1 
Included other somatic disorders 2 
Only mechanisms of action reported 1 
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Following this, nine papers were left which met the inclusion criteria. All 
included papers described IBS or IBS-type symptoms, no papers describing other 
FGIDs were found therefore this review will discuss the findings only as relating to 
IBS/IBS-type symptoms. The reference lists of these papers were searched and no 
further studies were identified. Therefore, nine papers are included in this review. 
The literature search strategy and application of exclusion criteria resulted in 
nine papers being included in this review, the details of which are described in Table 
4 below. First a summary of findings of the effectiveness of mindfulness for IBS 
symptoms are presented and then the papers are discussed according to three 
proposed review questions: 
1. What are the rationales for offering mindfulness-based therapies to 
individuals with IBS symptoms and how do the mindfulness-based therapies chosen 
reflect these? 
2. How do the study designs impact the generalisability of findings? 
3. Which conceptual issues should inform future trial designs? 
n.b. Four of the nine papers in this review have come from the same research 
group and have the same first author (Ljótsson). In order to maintain clarity when 
discussing the papers I will refer to (Ljótsson, Falk, et al., 2010) as Ljótsson 1 et al. 
(2010), (Ljótsson, Hedman, Lindfors, et al., 2011) as Ljótsson 2 et al. (2011), 
(Ljótsson, Hedman, Andersson, et al., 2011) as Ljótsson 3 et al. (2011) and 
(Ljótsson, Andersson, Andersson, et al., 2011) as Ljótsson 4 et al. (2011). 
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Table 4  
Characteristics of studies 
Author 
(date) 
Population 
Recruitment 
source 
N 
Exp 
(% 
female) 
N 
Control 
(% 
female) 
Intervention Intervention 
delivery 
Intervention 
duration 
Control Assessed outcomes Outcomes at end of 
intervention 
Months 
follow 
up 
Outcomes at follow 
up 
Ljótsson 
3 et al. 
(2011) 
IBS (self-
referral from 
community) 
98 97 Exposure-
based CBT 
(ICBT) 
Internet 
(same 
protocol as 
Ljótsson 1 et 
al (2010) 
10 weeks Stress 
managem
ent 
IBS symptoms (GSRS-
IBS), QoL (IBS-QoL), 
GI specific anxiety 
(VSI),negative thoughts 
about bowel function 
(CFSBD), stress (PSS), 
depression and anxiety 
(HADS) 
Significant improvements in 
both groups but significantly 
greater in the active group for 
symptom severity, QoL, GI 
specific anxiety and negative 
thoughts about bowel function, 
no differences between groups 
on stress or depression and 
anxiety 
6 Improvements 
maintained at follow 
up. Significant 
differences between 
groups on % 
reporting adequate 
relief from IBS 
pain/discomfort 
(65% vs. 44%) 
Zernicke 
et al. 
(2013) 
IBS 
(gastroentero
logist and 
self-
referrals) 
43  
(90%) 
47 
(87%) 
MBSR Face to face 
groups 
8 weeks(8x90 
minute 
sessions + 
1x3 hour 
retreat) 
Waiting 
list 
IBS symptom severity 
(IBS-SSS), QoL (IBS-
QoL), mood (POMS), 
stress (C-SOSI), 
spirituality (FACIT-sp) 
Significant improvements in 
IBS symptoms, QoL, mood, 
stress and spirituality 
6 Improvements of 
IBS symptoms and 
QoL maintained at 
follow up, 
difference between 
MBSR and control 
group no longer 
significant (waitlist 
also improved), 
rebound effects on 
stress and mood in 
MBSR group 
Ljótsson 
1 et al. 
(2010) 
IBS (self-
referral from 
community) 
42  
(83%) 
43 Mindfulness 
+ CBT 
(exposure) 
Internet 
delivered 
self-help, 
access to an 
online forum, 
email/telepho
ne contact 
with a 
psychologist 
10 weeks Wait list IBS symptom severity 
(gastrointestinal 
symptom diary) (GSRS-
IBS), QoL (IBS-QoL), 
GI specific anxiety (VSI) 
depression (MADRS-S), 
disability (Sheehan 
Disability Scales) 
Significant large effects on IBS 
symptoms, (40% of MG 
showed clinically significant 
improvement vs. 2% in the 
control group) and QoL, 
moderate effects on GI specific 
anxiety and small effects on 
depression and disability 
3 Improvements in 
IBS symptoms 
maintained, further 
significant 
improvements in 
QoL 
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- 
Ljótsson 
2 et al. 
(2011) 
Reports 
follow up 
data from 
Ljótsson et al 
(2010) 
75 
(included 
control 
group 
after 
cross 
over) 
N/A       15-18 
(mean=1
6.4) 
Improvements in 
IBS symptoms, QoL 
and GI specific 
anxiety maintained. 
59% report adequate 
relief from IBS pain 
or discomfort 
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Gaylord 
et al. 
(2011) 
IBS (self-
referral from 
community) 
36 
(100%) 
39 Mindfulness-
based stress 
and pain 
management 
programme 
Group 8 weeks (8x2 
hour sessions 
+ 1x4 hour 
session) 
Support 
group 
IBS symptom severity 
(IBS-SS total score), 
pain (abdominal pain 
subscale of IBS-SS), 
QoL (IBS-QoL), 
depression (BSI-18), 
anxiety (BSI-18) 
Significant decreases in 
symptom severity between 
groups, clinically significant 
improvement seen in 69% MG 
and 45% SG, non-significant 
changes in QoL, psychological 
distress or visceral anxiety 
3 Further decreases in 
symptom severity, 
changes in QoL, 
psychological 
distress and visceral 
anxiety reach 
significance 
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------  
Faurot et 
al. (2014) 
Reports 
follow up 
data from 
Gaylord et al 
(2011) 
33 35       12 Further significant 
decreases in 
symptom severity, 
psychological 
distress and visceral 
anxiety and 
significant 
improvement in 
QoL vs. SG 
Berrill et 
al. (2014) 
IBD patients 
in remission 
with IBS 
symptoms or 
high 
perceived 
stress levels 
(gastroentero
logy clinics) 
33 
(76%) 
33 Multi 
convergent 
therapy 
(mindfulness 
meditation + 
cognitive 
behavioural 
components) 
Face to face 
individual 
16 weeks 
(6x40 minute 
sessions) 
TAU QoL (IBDQ), relapse 
rate (FC), stress (RDHS, 
PSQ, WCC) 
Non-significant increase in 
QoL (IBDQ) scores in active 
vs. control; differences reach 
significance if only the 
subgroup with IBS symptoms 
at baseline are included. No 
differences in relapse rates of 
IBD (FC), both groups showed 
a reduction in stress that did not 
reach statistical significance 
12 Improvement in 
QoL (IBDQ) 
remains non-
significant 
Ljótsson 
4 et al. 
(2011) 
IBS 
(gastroentero
logy clinics 
consecutive 
sampling) 
30 
(77%) 
31 
(71%) 
Exposure-
based CBT 
(ICBT) 
Internet 
(same 
protocol as 
Ljótsson et al 
(2010) 
10 weeks Waiting 
list 
IBS symptoms (GSRS-
IBS), healthcare costs 
(TIC-P), QoL (IBS-
QoL), GI specific 
anxiety (VSI), disability 
(Sheehan Disability 
Scales) 
Significant medium effect sizes 
for improvements of IBS 
symptoms, QoL, GI specific 
anxiety for treatment 
completers, small effect sizes if 
using ITT analysis, ICBT was 
shown to be cost-effective 
12 Improvements 
maintained at follow 
up and increased for 
QoL 
Zomorodi 
et al. 
(2014) 
IBS (hospital 
and 
gastroenterol
ogy clinics) 
12 
(50%) 
24 
(48%) 
MBSR Face to face 
groups 
8 weeks (8x2 
hour sessions) 
12 IBS in 
CBT 
group, 12 
healthy 
controls 
IBS disease intensity 
(gastroenterologist 
completed questionnaire) 
Not reported 2 IBS disease intensity 
reduced in MBSR 
group compared to 
CBT group or 
control, many data 
not reported 
ICBT= Internet-based Cognitive Behavioural Therapy, GSRS-IBS=Global Symptoms Rating Scale- Irritable Bowel Syndrome, IBS-Qol=Irritable Bowel Syndrome Quality of Life, VSI=Visceral Sensitivity Index, CFSBD=Cognitive Scale for 
Functional Bowel Disorders, PSS=Perceived Stress Scale, HADS=Hospital Anxiety and Depression Scale, QoL=quality of life, GI=gastrointestinal, MBSR=mindfulness-based stress reduction, IBS-SSS=Irritable Bowel Syndrome Symptom Specific 
Scale, POMS=Profile of Mood States, C-SOSI=Calgary Symptoms of Stress Inventory, FACIT-sp=Functional Assessment of Chronic Illness Therapy-spiritual wellbeing scale, MADRS-S=Montgomery Asberg Depression Rating Scale-Self report, 
MG=mindfulness group, BSI-18=Brief Symptom Inventory-18, SG=support group, IBD=irritable bowel disease, TAU=treatment as usual, IBDQ=Irritable Bowel Disorder Questionnaire, FC=faecal calproctin level, RDHS=Revised Daily Hassle Scale, 
PSQ=Perceived Stress Questionnaire, WCC=Ways of Coping Checklist, TIC-P=Trimbos and Institute of Medical Technology Assessment Cost Questionnaire for Psychiatry, ITT=intention to treat analysis 
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Summary of findings of effectiveness of mindfulness for IBS symptoms 
 Table 5 shows the effect sizes of mindfulness-based interventions on IBS 
symptom severity and quality of life. These findings are taken from Aucoin et al. 
(2014). Effect sizes for the additional paper including in this review (Faurot et al., 
2014) could not be calculated as standard deviations were not reported. 
Table 5  
Effect sizes of mindfulness-based interventions on IBS symptoms and quality of life 
Author & date IBS severity at 
end of 
intervention 
IBS severity at 
postintervention 
follow-up 
Quality of life 
Berrill et al. (2014) .41 .33 -- 
Gaylord et al. (2011) 
Faurot et al. (2014) 
.36 
-- 
.15 
-- 
.24 
-- 
 
Ljótsson 1 et al. (2010) 
Ljótsson 2 et al. (2011) 
1.21 
-- 
-- 
-- 
-- 
.96 
Ljótsson 3 et al. (2011) .78 -- .79 
Ljótsson 4 et al. (2011) .35 .42 .51 
Zernicke et al. (2013) .50 .16 .45 
Zomorodi et al. (2014) -- 1.16 -- 
Pooled effects  .59  
(95% CI=  
.33 to .86) 
.35  
(95% CI= 
 .11 to .59) 
.56  
(95% CI= 
 .34 to .79) 
  
Quality assessment of the reviewed papers revealed unclear or high risk of 
bias using the Cochrane risk of bias assessment, largely related to inconsistent 
blinding of participants and absence of blinding of facilitators (although this is an 
inherent difficulty in most trials of psychological therapies), and incomplete data due 
to high rates of attrition.  
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1. What are the rationales for offering mindfulness-based therapies to 
individuals with IBS symptoms and how do the mindfulness based therapies 
chosen reflect these? 
Mindfulness-based therapies are a relatively recent area of research in IBS. 
Researchers have chosen to investigate its effectiveness for IBS and their reasons for 
doing so may vary and are not always described. First I will review what the studies 
stated were the problems related to IBS and then whether the interventions 
investigated in the studies were designed to specifically target the stated problems.  
The types of mindfulness-based therapies used in each of the studies will then be 
discussed, along with the choice of approach and then to what extent the studies 
discuss possible mechanisms through which their chosen intervention targeted the 
specified problems related to IBS. 
What do the studies state are the problems related to IBS? The nine 
papers together described the results from seven studies, with Faurot et al. (2014) 
and Ljótsson 2 et al. (2011) describing follow up results of already published studies 
(Gaylord et al., 2011 and Ljótsson 1 et al., 2010 respectively). Table 6 shows the 
breakdown of what each of the papers stated were the problems related to IBS.  
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Table 6  
Stated problems related to IBS 
Author & date Burden of 
symptoms 
Reduced health-
related quality of life 
Societal 
costs 
Psychiatric 
co-morbidity 
Berrill et al. (2014)  X   
Gaylord et al. (2011) 
Faurot et al. (2014) 
X 
X 
X 
X 
X 
X 
 
Ljótsson 1 et al. (2010) 
Ljótsson 2 et al. (2011) 
X X X 
X 
 
Ljótsson 3 et al. (2011) X  X  
Ljótsson 4 et al. (2011)  X X  
Zernicke et al. (2013) X    
Zomorodi et al. (2014)  X  X 
 
Three papers described the primary problems of IBS to be symptoms 
including abdominal pain (Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Zernicke 
et al., 2013) whilst four others described reduced quality of life to be the primary 
problem related to IBS (Berrill et al., 2014; Ljótsson 1, et al., 2010; Ljótsson 4, et al., 
2011; Zomorodi, Abdi, & Tabatabaee, 2014). Only one study (Gaylord et al., 2011) 
reported both symptoms and reduced quality of life to be the primary problems 
related to IBS. Additional stated problems related to IBS were societal costs such as 
health care burden and lost productivity due to days off work (Gaylord et al., 2011: 
Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Ljótsson 4 et 
al., 2011). Although several studies mentioned high levels of comorbidity of IBS 
with psychological disorders, only Zomorodi et al. (2014) described this as a 
problem related to IBS. Overall the studies did not go into details about the problems 
of IBS that their studies proposed to address. 
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Are the interventions designed to target the specified problems of IBS? 
In order to clarify the rationale for using mindfulness-based therapies for IBS, it 
might be expected that the authors would clarify which specific IBS-related 
problems they targeted with their intervention. Three studies made no direct 
comment about which problems of IBS they used the intervention to target (Berrill et 
al., 2014; Zernicke et al., 2013; Zomorodi et al., 2014). The remaining four studies 
(Gaylord et al., 2011; Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et 
al., 2011; Ljótsson 4 et al., 2011) all stated that they expected their intervention to 
target IBS symptoms and lead to an improvement in symptomatology. Gaylord et al. 
(2011) substantiated their expectations by discussing previous findings of MBSR in 
reducing stress and pain, stating that pain is a prominent symptom in IBS and stress 
exacerbates IBS symptoms, and so concluding that MBSR should be a reasonable 
treatment approach. Ljótsson 1 et al. (2010) and Ljótsson 2 et al. (2011) were even 
more specific in their expectations of how a mindfulness intervention would target 
problems related to IBS: they stated that their treatment approach (mindfulness and 
CBT) targeted GI-specific anxiety (GSA) and IBS-related avoidance behaviours. As 
GSA is thought to maintain symptoms of IBS through positive feedback loops 
between symptoms and anxiety, treatment would therefore lead to a decrease in IBS 
symptoms. All three studies from the Swedish research group (Ljótsson 1 et al., 
2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Ljótsson 4 et al., 2011) also 
expected that their mindfulness interventions would also lead to improvement in 
quality of life. Although several studies had previously cited high healthcare burden 
and lost work days as a problem of IBS, only Ljótsson 4 et al. (2011) stated that they 
expected their intervention to be cost-effective and to lead to reductions in these 
associated societal costs.  
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Types of mindfulness therapy used. Many different therapeutic 
approaches/protocols have been developed and researched that include mindfulness 
as a central component (MBSR, MBCT, ACT, DBT), as well as mindfulness being 
delivered in separate idiosyncratic protocols. The seven studies included in this 
review covered a range of mindfulness-based therapies, each with differences in 
approach that may have influenced their results. Only one study used the well-
researched and manualised MBSR approach (Zernicke et al., 2013). Delivered in a 
group format over eight weeks with a retreat towards the end of the programme, it 
purported to follow the MBSR protocol but with reduced session lengths (90 minutes 
as opposed to the original 150 minute sessions and with a half as opposed to a full 
day retreat). The authors stated that these changes were due to practical limitations of 
their therapeutic setting. A second study (Gaylord et al., 2011) used an adapted 
version of MBSR they called a “mindfulness-based stress and pain management 
programme”, adapted for an IBS population by encouraging the use of mindfulness 
to notice sensations in the abdominal region. This was also delivered in a group 
format over eight weeks with reduced session lengths (two hour weekly sessions and 
a half day retreat).  
Four studies reported using mindfulness-based protocols which included 
elements of CBT (Berrill et al., 2014; Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; 
Ljótsson 3 et al., 2011; Ljótsson 4 et al., 2011). Berrill et al. (2014) reported using 
“multi-convergent therapy” (MCT) which they stated had mindfulness as the central 
component of therapy alongside aspects of CBT. Delivered in an individual format 
in six 40 minute sessions spread over 16 weeks, MCT had a much reduced contact 
time compared to the group-based approaches. All three studies from the Swedish 
research group (Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 
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2011; Ljótsson 4 et al., 2011) used the same protocol that they called “internet 
delivered cognitive behavioural therapy” (ICBT), a 10 week protocol originally 
developed as a group treatment (Ljótsson, Andréewitch, et al., 2010). Participants 
received the treatment as a text-based self-help manual (delivered via the internet but 
on printer friendly pages) divided into five steps. The first four steps (intended to be 
delivered weekly) provided psychoeducation and mindfulness instruction. The fifth 
step gave instructions on IBS-related exposure exercises and how to use mindfulness 
during them and was intended to be followed for five weeks. Whilst participants 
received the internet-delivered therapy individually, they had access to a closed 
online forum for all participants and were encouraged to post group discussions on 
it. Zomorodi et al. (2014) provided no details of the mindfulness intervention used in 
their study. 
Choice of approach. None of the studies explicitly stated their rationale for 
choosing the particular mindfulness-based approach they adopted. Gaylord et al. 
(2011) described the research evidence for the efficacy of MBSR with chronic 
functional disorders and so by extension the reader is led to assume that this is the 
reason why they chose to deliver an adapted version of the MBSR protocol. 
However, they do not discuss any reasons for why MBSR was selected above 
alternative mindfulness-based approaches. The three studies using the ICBT protocol 
(Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Ljótsson 4 et 
al., 2011) provided a rationale for the exposure component of their protocol with 
reference to its efficacy in previous research, but again did not provide any 
information for the selection of the mindfulness component.  No rationale for 
intervention choice was provided by the remaining three studies (Berrill et al., 2014; 
Zernicke et al., 2013; Zomorodi et al. 2014). 
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Proposed mechanisms. In order for readers and future researchers to be 
confident of the internal validity of any reported improvements in IBS following a 
mindfulness-based intervention, the proposed mechanisms of the approach should be 
discussed. 
Berrill et al. (2014) did not describe any proposed mechanisms for how their 
mindfulness-based therapy would lead to improved outcomes for patients with IBS 
symptoms, only that they hypothesised that it would, and that a reduction in IBS 
symptoms would then lead to an improvement in quality of life. Zomorodi et al. 
(2014) was equally vague on description of proposed mechanisms of mindfulness for 
IBS, stating that mindfulness would ‘affect’ the brain-gut axis and thereby reduce 
symptoms.  
The remaining five studies provided more details on proposed mechanisms. 
Gaylord et al. (2011) admitted that “to date mechanisms are poorly understood” but 
hypothesised several possibilities. They proposed that psychological treatments in 
general can act directly on the brain-gut axis by modifying the perception of 
sensations from the gut, or indirectly by reducing unhelpful thoughts, negative 
emotions and stress that influence the brain-gut axis and lead to disturbance of the 
gut. They also stated that neurocognitive research on mindfulness has demonstrated 
changes in neural activation in regions associated with interoception (perception of 
internal stimuli) and emotional regulation following training in mindfulness. As IBS 
has been associated with heightened perception of gut-related pain and anxiety, they 
proposed that mindfulness may improve IBS symptoms by influencing this 
interoception. They went further to state that “mindfulness training for IBS may act 
through a number of therapeutic mechanisms, including increasing non-reactivity to 
gut-focused anxieties and catastrophic thoughts about the ability to manage pain; 
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enhancing awareness of IBS symptoms as innocuous interoceptive signals rather 
than threats to wellbeing; decreasing psychophysiological stress; and facilitating 
attentional disengagement from gut sensations and obsessive thoughts about visceral 
function” (Gaylord et al, 2011, p. 1686). Using the data from Gaylord et al. (2011), 
Garland et al. (2012) furthered the discussion on proposed mechanisms by 
conducting a path analysis on mediators between mindfulness therapy and 
improvement in IBS symptoms and quality of life. Their resultant model proposed 
that mindfulness therapy “led to increased nonreactivity to cognitions, emotions, and 
physiological sensations which in turn was associated with decreased visceral 
sensitivity” (Garland et al., 2012, p.598). 
Although with differing levels of specificity, the three studies discussed so 
far all proposed that mindfulness-based therapies would lead to a reduction in IBS 
symptoms (which would then presumably lead to an improvement in quality of life 
and/or decreased associated costs and burdens). In contrast, the other four studies 
(Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Ljótsson 4 et 
al., 2011; Zernicke et al., 2013) proposed the reverse order of influence; that 
mindfulness-based approaches would lead to improvement in quality of life and that 
that would then influence symptoms, not necessarily by improving them, but by 
improving coping or decreasing burden. 
The three studies from the Swedish research group (Ljótsson 1 et al., 2010; 
Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; Ljótsson 4 et al., 2011) all suggested 
that in their ICBT protocols that (1) mindful exposure to IBS symptoms and related 
GI-specific anxiety (GSA) would lead to extinction of symptom-related anxiety; and 
(2) mindfulness-mediated acceptance of symptoms, as opposed to avoidance or 
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attempts at control, would lead to an improved quality of life. Reduction of GSA and 
increases in quality of life would then lead to a decreased burden of symptoms. 
Zernicke et al. (2013) proposed that mindfulness would increase IBS 
patients’ coping with IBS symptoms by facilitating monitoring and regulation of 
their own arousal. They suggested that this would allow patients with IBS to “gain 
awareness and evaluate problems with greater emotional stability”. Increased coping 
with symptoms would presumably lead to improvements in quality of life and 
decreased symptoms burden. 
2. How do the study designs affect generalisability of findings? 
The second question this review aims to answer is how the designs of the 
studies included in the review influence the generalisability of their findings, and in 
extension to this question, how future studies may adapt their designs to increase the 
relevance of any findings.  
Participants/samples. One important aspect of study design is to recruit 
participant samples representative of the population of interest. This means including 
as many of the characteristics of interest as possible, whilst keeping the sample as 
homogenous as possible to reduce introducing error from extraneous variables. 
IBS Rome criteria. Berrill et al. (2014) was the only study in this review that 
did not recruit participants diagnosed with IBS. They recruited participants with 
diagnoses of IBD (either Crohn’s or ulcerative colitis) in clinical remission (judged 
by the affected individual and her/his physician) and with either symptoms of IBS 
(according to Rome III criteria) or high perceived stress levels. Their rationale was 
that previous reviews had concluded that psychological therapies were not effective 
in improving symptoms or quality of life for IBD patients but suggested that research 
should focus on the potential benefits for certain subgroups of IBD patients  
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(Timmer et al., 2011). The remaining six studies recruited participants with IBS 
according to Rome criteria, Gaylord et al. (2011) used Rome II criteria, and Ljótsson 
1 et al. (2010)/Ljótsson 2 et al. (2011), Ljótsson 3 et al. (2011), Ljótsson 4 et al. 
(2011), Zernicke et al. (2013) and Zomorodi et al. (2014) used Rome III criteria as 
their benchmark.  
The Rome II and III criteria are identical except for Rome II stating that 
symptoms are required to be present for at least 12 (non consecutive) weeks out of 
the previous 12 months, whereas Rome III requires symptoms to be present at least 
three days per month and to have persisted for at least three months with first onset 
of symptoms at least six months prior to diagnosis. Although the slightly stricter 
criteria of Rome II means that participants in the Gaylord et al. (2011) study may 
have represented a slightly more severe subset of patients with IBS compared to the 
remaining studies, the difference is small and unlikely to have a large effect. 
Ljótsson 1 et al. (2010)/Ljótsson 2 et al. (2011) and Ljótsson 3 et al. (2011) 
required their self-referred participants to declare that they had received a diagnosis 
of IBS and checked for presence of ‘alarm symptoms’ that would lead to exclusion, 
but did not check IBS diagnoses themselves and so were unable to conclusively state 
that their sample met Rome III criteria. In Ljótsson 3 however, the IBS diagnoses 
were all made by gastroenterologists, as was the case in Gaylord et al. (2011), 
Zernicke et al. (2013) and Zomorodi et al. (2014), either as part of the study or prior 
to inclusion but verified by medical records. Severity of IBS symptoms pre-
intervention for participants who self declared that they met Rome III criteria in 
Ljótsson 1 et al. (2010), Ljótsson 2 et al. (2011) and Ljótsson 3 et al. (2011) was 
greater than for the participants who were assessed as meeting Rome III criteria by a 
gastroenterologist in Ljótsson 4 et al. (2011). It is therefore unlikely that the lack of 
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gastroenterologist confirmation of diagnosis led to inclusion of non-representative 
participants. 
Recruitment locations. Berrill et al. (2014) recruited participants from 
Wales, UK, Gaylord et al. (2011) recruited from North Carolina, USA, Ljótsson 1 et 
al. (2010)/Ljótsson 2 et al. (2011), Ljótsson 3 et al. (2011) and Ljótsson 4 et al. 
(2011) all recruited from Stockholm County, Sweden, Zernicke et al. (2013) 
recruited from Alberta, Canada and Zomorodi et al. (2014) from Tehran, Iran. Most 
studies made contact with potential participants through gastroenterological clinics, 
either by reviewing medical records for suitable participants, or identifying potential 
participants when they attended gastroenterological consultations (Berrill et al., 
2014; Gaylord et al., 2011; Ljótsson 4 et al., 2011; Zernicke et al. 2013; Zomorodi et 
al., 2014). Ljótsson 1 et al. (2010)/Ljótsson 2 et al. (2011) and Ljótsson 3 et al. 
(2011) exclusively accepted self-referrals from interested individuals following 
advertisements in online discussion forums, newspapers, websites or flyers at 
gastroenterology clinics. Gaylord et al. (2011) and Zernicke et al. (2013) accepted 
self-referrals as well as approaching participants directly. These differences in 
recruitment methods may have led to participant samples with different levels of 
motivation and interest in the study, and possibly different baseline levels of 
symptomatology. The self-referral method used by Ljótsson 1 et al. (2010)/Ljótsson 
2 et al. (2011) and Ljótsson 3 et al. (2011) is likely to have led to a sample that 
included participants with high levels of motivation to take part (they volunteered 
without prompting), high likelihood of believing the intervention will benefit them 
and so more motivated to complete the intervention (for example “take the correct 
dose”) and be more likely to be at a stage in their life of living with IBS where they 
have already tried alternative methods of management and are now ready and willing 
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to try a psychological approach. Contrast this to the sample method used in Ljótsson 
4 et al. (2011) where participants were identified from consecutive first visits to a 
gastroenterologist and almost all eligible participants were invited to take part in the 
study. This group is more likely to have had a much shorter duration of living with 
IBS (as this was their first visit to a gastroenterologist), less likely to have already 
fully explored alternative management options such as diet and medication and so 
may have lower levels of motivation for, and belief in, the possibility for a 
psychological intervention to have benefit, or the necessity to try a psychological 
approach at that time. Ljótsson 4 et al. (2011) commented on this difference, noting 
the much higher attrition and non-completion rates in their sample compared to 
earlier studies from their research group (Ljótsson 1 et al., 2010; Ljótsson 2 et al., 
2011; Ljótsson 3 et al., 2011). 
Exclusion criteria- were Axis I disorders excluded? There is a high level 
of comorbidity in adults, up to 94% (Whitehead et al., 2002), between IBS and 
psychiatric diagnoses including DSM 5 Axis I disorders such as anxiety and 
depression.  Representative samples would reflect these high levels of comorbidity 
by including participants with diagnosed/non-diagnosed psychiatric disorders. 
Berrill et al. (2014) included participants with comorbid diagnoses of 
psychiatric disorders, including those taking psychotropic medication (as long as this 
had not changed in the previous three months), but excluded those that had received 
psychological therapy.  A total of 47 participants were excluded from participation 
but no data were provided as to what proportion of these had previously received 
psychological therapy, or for what disorder. 
Gaylord et al. (2011) excluded participants with a diagnosis of mental illness 
with psychosis, or those who had had an inpatient admission for a psychiatric 
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disorder in the previous two years. This resulted in 12 exclusions. This would 
presumably have enabled participants with psychological/psychiatric difficulties 
without psychosis or recent inpatient admissions to take part in the study, increasing 
representativeness of the sample. 
Ljótsson 1 et al. (2010)/Ljótsson 2 et al. (2011) and Ljótsson 3 et al. (2011) 
used online screening tools to identify potential participants with severe depressive 
symptoms, suicidal ideation, and substance dependence, followed by a diagnostic 
interview over the phone, and they then excluded these participants. Ljótsson 1 et al. 
(2010)/Ljótsson 2 et al. (2011) additionally excluded participants with psychosis, 
manic episodes or anorexia, although these criteria only resulted in two exclusions, 
one for severe depressive symptoms, and one for suicidal ideation. In Ljótsson 3 et 
al. (2011), two participants were excluded for severe depressive symptoms. 
Ljótsson 4 et al. (2011) excluded any potential participants “judged to be 
highly unsuitable for ICBT for somatic or psychological reasons as assessed by the 
gastroenterologist” resulting in two participants being excluded for “psychiatric 
reasons” (p. 3). No further details are provided and so it is unknown whether these 
represented common psychological problems such as depression and anxiety or other 
issues such as psychosis, or what criteria theses assessments were based on. 
Zernicke et al. (2013) had the most exclusive criteria for participants: 
“concurrent self-reported diagnosis of a DSM-IV Axis I mood, anxiety, or psychotic 
disorder” (p. 387). In their discussion, Zernicke et al. (2013) comment that this 
exclusion criterion limits the generalisability of their findings because of the high 
prevalence rates of mood and anxiety disorder within IBS populations, but that they 
did it for a “clean sample”(p.394).  One of the findings of the Zernicke et al. (2013) 
study is an improvement in mood following the MBSR programme, so it would be 
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interesting to know whether inclusion of participants with mood or anxiety disorders 
would have resulted in even greater observed improvement in mood following 
MBSR, or less. At entry into the study participants’ scores on the Profile of Mood 
States (POMS) questionnaire were 48.6 (s.d. 36.7) in the MBSR group and 50.1 (s.d. 
36.3) in the control group. This was a much higher score than for a normative adult 
sample which reported scores of 14.8 (s.d. 32.7) for men and 20.3 (s.d. 33.1) for 
women (Nyenhuis, Yamamoto, Lucheta, Terrien, & Parmentier, 1999). Following 
treatment scores had fallen to 28.5 (s.d. 45.9) in the MBSR group and 37.4 (s.d. 
41.8) in the control group, remaining higher than the normative population. Given 
the evidence of efficacy of MBSR in improving symptoms/quality of life for 
individuals with mood or anxiety disorders, and for those with IBS, it would be 
reasonable to assume that for individuals with comorbid mood/anxiety disorders and 
IBS, MBSR could lead to benefits through several different therapeutic mechanisms. 
Zomorodi et al. (2014) published no information about inclusion/exclusion of 
psychiatric disorders. Of the studies that stated the number of potential participants 
excluded on the basis of concurrent psychological/psychiatric diagnoses, the 
excluded participants represent between 1-16% of the eventual sample. Comparing 
these relatively small numbers to the much higher published comorbid rates in the 
general IBS population, this suggests that many participants with comorbid 
psychological problems were included in the samples and therefore enhancing the 
generalisability of the findings. 
Outcome measures - do they sample the targeted problems of IBS? There 
was a high degree of overlap in the outcome measures used in the 7 studies. Two 
studies used IBS symptom severity as the primary outcome of their study, measured 
by the Irritable Bowel Syndrome Symptom Severity Scale (IBS-SSS) (Gaylord et al., 
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2011; Zernicke et al. 2013). The three studies from the Swedish research group also 
used IBS symptom severity as their primary outcome measure, but used the 
Gastrointestinal Symptoms Rating Scale modified for patients with IBS (GSRS-IBS) 
as their measure. Zomorodi et al. (2014) also stated IBS symptom severity as 
primary outcome but provided little detail of their measurement tool other than 
describing it as a questionnaire based on Rome III criteria and used by a 
gastroenterologist to ascertain IBS disease severity. Berrill et al. (2014) was alone in 
the included studies in using quality of life as measured by the Inflammatory Bowel 
Disease Questionnaire (IBDQ) as the primary outcome measure, although they did 
also collect data on symptom severity using the IBS-SSS. All other studies measured 
quality of life using the Irritable Bowel Syndrome Quality of Life questionnaire 
(IBS-QoL) except for Zomorodi et al. (2014), who did not report quality of life data. 
As the primary listed problems of IBS in most studies were the burden of 
symptoms of IBS and impact on quality of life, all the studies appear to have 
measured both of these constructs except for Zomorodi et al. (2014). Only one study 
(Ljótsson 4 et al., 2011) measured health economic data, despite many of the other 
studies stating high health economic costs to be a problem related to IBS.  
Measures of stress - floor effects or using a wellbeing measure? In 
addition to the primary outcome measures of IBS symptom severity and quality of 
life, the majority of studies measured several secondary outcomes. The most 
common of these was mood/stress as shown in Table 7.  
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Table 7  
Measures of mood/stress 
Author & date Mood measure Stress measure Symptom specific 
anxiety measure 
Berrill et al. (2014) HADS RDHS 
PSQ 
 
Gaylord et al. (2011) 
Faurot et al. (2014) 
 
BSI-18  VSI 
Ljótsson 1 et al. (2010) 
Ljótsson 2 et al. (2011) 
 
MADRS-S  VSI 
Ljótsson 3 et al. (2011) HADS PSQ VSI 
Ljótsson 4 et al. (2011)   VSI 
Zernicke et al. (2013) POMS C-SOSI  
Zomorodi et al. (2014)    
HADS= Hospital Anxiety and Depression scale, RDHS= Revised Daily Hassle Scale, PSQ= Perceived Stress Questionnaire, 
BSI-18= Brief Symptoms Inventory 18, MADRS-S= Montgomery Asberg Depression Rating Scale-Self report, POMS= 
Profile of Mood States, C-SOSI= Symptoms of Stress, VSI= Visceral Sensitivity Index 
 
Berrill et al. (2014) used the Hospital Anxiety and Depression scale (HADS) 
as well as the Revised Daily Hassle Scale (RDHS) and the Perceived Stress 
Questionnaire (PSQ). Gaylord et al. (2011) used the Brief Symptoms Inventory 18 
(BSI-18). Ljótsson 1 et al. (2010)/Ljótsson 2 et al. (2011) used the Montgomery 
Asberg Depression Rating Scale-Self report (MADRS-S), whilst Ljótsson 3 also 
used the HADS as well as a 10 item version of the PSQ. Zernicke et al. (2013) used 
the Profile of Mood States (POMS) and Symptoms of Stress (C-SOSI). Gaylord et 
al. (2011) and all three studies from the Swedish research group measured 
gastrointestinal-specific anxiety using the Visceral Sensitivity Index (VSI). The VSI 
is a 15 item questionnaire that aims to measure the degree of anxiety related to 
gastrointestinal symptoms. It asks respondents to rate how much they agree with 
statements such as “I often worry about problems in my belly”. 
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Of the four different measures of mood used across the studies, three were 
developed for use with medical populations (HADS, BSI and POMS) and only the 
MADRS-S was designed specifically for individuals with diagnosable depression. 
Although there are known links between levels of stress and IBS (for example stress 
exacerbating IBS symptoms), and high rates of comorbidity between IBS and 
psychiatric/psychological disorders (Whitehead et al., 2002), not everyone with IBS 
has high levels of anxiety or depression. It is therefore possible that the IBS patients 
rating their mood on the MADRS-S would have scored minimally on these measures 
pre-intervention resulting in it being very difficult to detect changes in the measures 
post-intervention (floor effects). However this does not appear to be the case in the 
data with the pre-intervention scores on the MADRS-S averaging around 25% of the 
possible total score, and the standard deviations being smaller than the mean and so 
not encompassing a score of zero.  
Blinding or controlling for being unable to blind and credibility checks 
In RCTs for pharmacological interventions, high quality designs use double or even 
triple blinding of treatment condition (either the participant, the participant and dose 
deliverer, or the participant, dose deliverer and data collector and/or data analyser are 
all unaware of which participants was in which trial arm). This is to control for 
expectancy of improvement, or placebo effects.  
It is almost impossible to achieve blinding of therapists in psychological 
interventions, and very difficult to achieve blinding of patients, since the treatment 
and the comparison usually differ in ways that are easy to identify, such as the 
control condition often being shorter, involving less face to face contact, etc. 
Additionally, ethical practice of informed consent often requires that patients are 
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aware of the conditions of each arm of the trial, meaning that they are likely to be 
able to match features of each condition to their allocated treatment.  
If blinding of participants is not possible, an alternative is to ask participants 
to rate the credibility of their allocated condition. In that way, outcomes can be 
compared against post-treatment guesses by participants about which condition they 
believed they received, and their level of belief in the efficacy of the treatment they 
were receiving (expectation of benefit). This is also good but not common practice in 
RCTs of pharmacological interventions: since side effects of drugs can unblind 
participants, participants should be asked at exit whether they believed they were in 
the active or placebo arm of the trial, and why. 
Four of the seven RCTs reviewed did not use an active control condition. In 
Berrill et al. (2014), participants were either assigned to the mindfulness-based 
therapy or received medical treatment as usual (TAU) from their gastroenterology 
team. Therefore participants were aware of which condition they were in. Ljótsson 1 
et al. (2010)/Ljótsson 2 et al. (2011), Ljótsson 4 et al. (2011), and Zernicke et al. 
(2013) all used TAU waitlist control groups. In their studies participants were either 
assigned to an immediate mindfulness-based therapy or were placed on a waiting list 
to receive the intervention several months later, and acted as controls during their 
waiting time. The participants in these studies would similarly not have been blinded 
as to treatment allocation and in addition may have had very low expectations of 
improvement during the waiting period as they knew they would receive the ‘active’ 
treatment in the future, though modest improvement on waiting lists are almost 
always seen due to the effects of being studied, paid attention to and having one’s 
concerns validated. 
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Only three studies used active control groups. The intention with an active 
control group is, as far as possible, to match the ‘active’ treatment on non-specific 
elements (for example duration, therapist attention, “dose”) and not to include any 
known ‘active’ elements. In their study, Gaylord et al. (2011) used an “IBS support 
group” as control condition. Although participants were not blinded to their 
allocation, the two treatments were presented as equal; patients were told that in 
previous studies both had been beneficial. All participants completed a credibility 
scale after their first treatment session, using the Borkovec and Nau attitudes towards 
treatments questionnaire (Borkovec & Nau, 1972). The authors reported no 
differences in the credibility ratings between the two groups, indicating that 
expectancy of benefit should have been approximately equal in both conditions. In 
addition to this, study staff involved in data collection and data management were 
masked to treatment allocation. 
Ljótsson 3 et al. (2011) used “Internet stress management (ISM)” as the 
control condition in their study, designed to contain elements common to all 
psychological interventions (a rationale for treatment, psychoeducation, practice of 
new behaviours and therapeutic alliance). Participants were not told about the 
differences between the two treatments, and were informed that both  had been 
shown to be beneficial in reducing IBS symptoms. Ljótsson 3 et al. (2011) also used 
the Borkovec and Nau credibility scale and reported equal scores in both groups. 
Zomorodi et al. (2014) used two control groups, but one consisted of healthy 
participants receiving no intervention and so was irrelevant. The active control group 
included participants with IBS receiving weekly CBT sessions to match the intensity 
of intervention for the mindfulness group. The authors did not report any blinding of 
participants/researchers or use of credibility checks. 
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The use of active control groups, together with validated credibility checks in 
the Gaylord et al. (2011) and Ljótsson 3 et al. (2011) studies represents good practice 
and enables readers to have greater confidence that the observed differences between 
groups following the interventions were due to the particular intervention, rather than 
to expectations of benefit or nonspecific effects common to all interventions. 
Participant adherence to the interventions. Once participants have been 
allocated to a particular treatment, it cannot be assumed that they will receive the 
intended “dose”. They may not attend all sessions or complete the intended 
homework. Therefore in order to make conclusions about the efficacy (or inefficacy) 
of an intervention it is important for researchers to record attendance and adherence. 
Berrill et al. (2014) make no mention of monitoring participants’ adherence. Gaylord 
et al. (2011) collected electronic daily diaries from participants including the number 
of minutes of mindfulness practice completed; they also reported the average number 
of sessions attended by participants.  
Ljótsson 1 et al. (2010) reported “neither therapist adherence nor the 
treatment activity of other participants was assessed in the study” (p.537). However, 
they did report the number of steps of the intervention participants completed, and 
participants had to report homework exercises for each step before being given 
access to the next step. In addition, participant contact with therapists was 
monitored. Although participants were asked to complete weekly diaries, these were 
only collected at the end and so it is unknown when participants completed them. 
Ljótsson 3 et al. (2011) and Ljótsson 4 et al. (2011) make no mention of participants’ 
adherence, but their studies closely matched that of Ljótsson 1 et al. (2010) and they 
are likely to have included a similar level of monitoring. 
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In Zernicke et al. (2013), participants kept daily meditation logs which were 
collected weekly, and facilitators recorded the number of sessions attended. The only 
mention of participant adherence in Zomorodi et al. (2014) was that in the CBT 
control condition, most participants did not complete their homework. It is unknown 
to what extent participants in the mindfulness group completed their homework. 
Zernicke et al. (2013) was the only study that additionally analysed 
adherence to the intervention. They reported that treatment completers (attended five 
or more out of the eight classes) showed a 31% reduction in IBS symptoms 
following the intervention, compared to a 17% reduction for participants who 
attended fewer than five classes.  
Protocol adherence. In addition to participants’ adherence to an 
intervention, the degree to which the facilitators adhered to the protocol affects the 
strength of the conclusions that can be drawn from the findings. Only Gaylord et al. 
(2011) reported monitoring facilitators’ compliance to their protocol through 
videotaping of sessions, and noted that no protocol deviations were observed. The 
three studies from the Swedish research group were all delivered via the internet and 
so intervention content and delivery was inherently standardised, but no explicit 
assessment of adherence to the manual was reported. Zernicke et al. (2013) and 
Zomorodi et al. (2014) make no mention of protocol adherence measures. 
3. Which conceptual issues should inform future trial designs? 
Placebo response. In the original Latin placebo means “I shall please” and 
the placebo effect describes “the beneficial... effect on health produced by a placebo 
that cannot be attributed to the properties of the placebo” (Placebo, n.d.).  
The placebo response is usually spoken of as a ‘nuisance’ effect adding error 
to be controlled for (and resulting in the need for a matched control condition) 
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(Critelli & Neumann, 1984). In pharmacological trials the aim is to demonstrate drug 
effectiveness ‘above and beyond’ the effects of the placebo treatment (an existing 
drug or an inert substance).  
Alternatively, the placebo response can be conceptualised not as a ‘nuisance’ 
but as an opportunity; evidence of the possibility for interventions conventionally 
thought of as ‘inert’ to have positive impact on health and wellbeing through patient 
expectations and through the procedures involved in any trial. In pharmacological 
trials for instance, the placebo response demonstrates that even without an active 
drug participants showed improvement in symptoms. Whilst understanding the 
components of the placebo effect may not help to develop better pharmacological 
substances, it may help develop better psychological approaches to healthcare as the 
placebo effect is mediated by psychological factors. The opportunity therefore is to 
identify what factors led to improvement in the placebo group? Or, alternatively, 
what are the ‘active ingredients’ of a placebo?  
There are several different aspects of the placebo effect: regression to the 
mean, natural course of the disease, Hawthorne effect, expectancy of improvement, 
attention, social support, validation of experience and a sense of agency (Barnett, 
van der Pols, & Dobson, 2005; Hróbjartsson & Gøtzsche, 2010; Linde et al., 2007; 
Stewart-Williams & Podd, 2004). The first two are the least psychological in nature. 
Regression to the mean (a statistical phenomenon) and the natural course of a disease 
are unlikely to have a large effect in IBS trials as IBS is a chronic disorder, without 
common spontaneous remission (Tanaka, Kanazawa, Fukudo, & Drossman, 2011). 
The remaining aspects are much more psychological in nature, although they 
can result in biological changes in the body such as changes in blood pressure 
(Meissner, 2011). The Hawthorne or observer effect refers to changes in 
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participants’ behaviour caused by an awareness of being observed (Adair, 1984). 
The expectancy of improvement effect largely relies on learning and socialisation to 
healthcare situations where interaction with a practitioner is associated with 
improvement in symptoms. This can occur at a conscious level, and additionally at 
an unconscious level. Verbal associations activate association areas in the brain and 
the body can respond unconsciously producing a placebo response (Frenkel, 2008) 
with modulated pain processing occurring in the spinal cord during placebo 
analgesia (Eippert, Finsterbusch, Bingel, & Büchel, 2009).  
The role of attention, social support and validation of patients’ experiences 
can be grouped together in terms of representing the positive patient-practitioner 
relationship. This relationship is likely to lead to an improvement in patients’ 
emotional and psychological wellbeing which then leads to improvement in 
symptoms, either directly through CNS involvement, or indirectly through better 
coping and improved health behaviours.  
The final example, a sense of agency, refers to the situation where a 
participant’s presence in a trial represents a deviation from a previous state of 
helplessness, for example their symptoms have not responded to other treatments and 
so taking part in a clinical trial provides a positive feeling of doing something rather 
than the despondency associated with doing nothing.  
In essence, much of the ‘placebo effect’ could alternatively be thought of as a 
‘positive care effect’ (Blease, 2012) as “the study of the placebo effect…is the study 
of the psychosocial context around the treatment and the patient, and it plays a 
crucial role in the therapeutic outcome” (Benedetti & Amanzio, 2011, p. 413). 
IBS is a condition in which there is a high degree of placebo response with an 
average placebo response rate of 40.2% in pharmacological trials of IBS (Patel et al., 
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2005) and 42.6% in complementary and alternative medicine trials of IBS (Dorn et 
al., 2007); this is in comparison to the mean placebo response rate in Crohn’s disease 
of 19% (Su, Lichtenstein, Krok, Brensinger, & Lewis, 2004). Although placebo 
effects have been reported in almost all medical conditions, those disorders with a 
stronger link with psychological processes are likely to show a greater response 
(Hróbjartsson & Gøtzsche, 2010). It is therefore understandable that IBS would 
demonstrate a high placebo response rate as psychological factors are key to the 
manifestation of the syndrome. High placebo response rates have additionally been 
demonstrated in open-label placebo trials for IBS where participants were truthfully 
informed that they were receiving “inert or inactive pills, like sugar pills” and given 
a rationale for why the placebo might be effective (Kaptchuk et al., 2010). 
Different control groups were used across the seven studies included in this 
review and so different degrees of placebo response may have operated. Kaptchuk et 
al. (2008) demonstrated three levels to the placebo response in IBS trials; assessment 
and observation, a therapeutic ritual, and a supportive patient-practitioner 
relationship. Three of the seven reviewed studies (Gaylord et al., 2011; Ljótsson 3 et 
al., 2011; Zomorodi et al., 2014) utilised an active control group (encompassing all 
three levels) and so would be expected to show a larger placebo response as their 
control group would have had higher expectancy of improvement than participants in 
the waitlist control groups of the other studies. This pattern is indeed shown in the 
data for IBS severity and more clearly for IBS quality of life as shown in Table 8 and 
9 and Figure 1 and 2.  
  
51 
Table 8 
IBS severity in the control group 
Study Pre 
intervention 
Post 
intervention 
% change 
post 
intervention 
Follow 
up 
% change 
follow up 
Gaylord et al. (2011) 287 a 269 a 6.3% 261 a 9.1% 
Ljótsson 3 et al. (2011) 47.3b 41.1b 13.1% 39.3b 16.9% 
Zomorodi et al. (2014) 17.83c   16.8c 5.8% 
Berrill et al. (2014) 221 a 206 a 6.8% 224 a -1.4% 
Ljótsson 1 et al. (2010) 49.6b 47.3b 4.6%   
Ljótsson 4 et al. (2011) 39.8b 40.9b -2.8%   
Zernicke et al. (2013) 249 a 230 a 7.6% 213.8 a 14.1% 
 
a =IBS-SSS    b =GSRS-IBS  c=unspecified disease intensity measure   
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1. Improvements in IBS symptoms (IBS-SSS) observed in the control groups 
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Table 9 
IBS quality of life in the control group 
Study Pre 
intervention 
Post 
intervention 
% change 
post 
intervention 
Follow 
up 
% change 
follow up 
Gaylord et al. (2011)  67.4 b 70.9 b 5.2% 70.5 b 4.6% 
Ljótsson 3 et al. (2011)  55.5 b 65.7 b 18.4% 68.7 b 23.8% 
Zomorodi et al. (2014)      
Berrill et al. (2014)  149 a 145 a -2.7% 137 a -8.1% 
Ljótsson 1 et al. (2010) 53.8 b 52.9 b -1.7%   
Ljótsson 4 et al. (2011) 76.1 b 67.4 b -11.4%   
Zernicke et al. (2013)   61.6 b 63.1 b  2.44% 66.5 b 8.0% 
 
a =IBDQ    b =IBS-QoL 
    
 
  
 
Figure 2. Improvements in health related quality of life (IBS-QoL) observed in the control 
groups 
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Reference to the brain-gut axis. Gaylord et al. (2011) reported that “brain-
gut interactions are recognised to have a prominent role in modulating gut function” 
(p.1679) and gave an explanation of brain gut interactions as previously described in 
the introduction. Zernicke et al. (2013) also mention that “chronic GI symptoms are 
generated by a combination of intestinal, motor, sensory and central nervous system 
activity termed the “brain-gut axis”” (p.386) and Zomorodi et al. (2014) made a 
fleeting reference to the brain-gut axis in their introduction. However Berrill et al. 
(2014) and the three Swedish research group papers made no reference to the brain-
gut axis. 
Explanatory theories of IBS. Explanatory theories of IBS propose that 
changes in the brain-gut axis lead to increased sensitivity of the gut, and changes to 
the interactions between microflora (bacteria in the gut), the cells lining the gut, and 
the immune system (Tillisch & Labus, 2011).  None of the studies reviewed directly 
discussed explanatory theories of IBS distinct from discussion of the brain-gut axis. 
How is mindfulness linked to the brain-gut axis? Berrill et al. (2014), and 
the three Swedish research group papers made no reference to the brain-gut axis as it 
relates to mindfulness, and neither did Zernicke et al. (2013). Gaylord et al. (2011) 
suggested that mindfulness meditation would influence psychological factors 
associated with IBS such as heightened perception of intestinal pain, selective 
attention to gastrointestinal sensations and anxiety about the significance of those 
sensations. Although they did not express it directly, their implication was that this 
would then lead to an improvement in gastrointestinal symptoms through brain-gut 
axis connections. Zomorodi et al. (2014) made similar comments, stating that 
mindfulness can reduce the brain activity of regions involved in emotion regulation 
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and pain processing, thereby influencing the brain-gut axis and leading to an 
improvement in symptoms. 
Neuropsychological theories. There was very little discussion of 
neuropsychological theories in the studies, other than in relation to the brain-gut axis 
as described above. 
Discussion 
Summary of findings 
The research reviewed will be summarised and discussed in relation to the 
original findings of Aucoin et al. (2014) and the three aims of this review. 
Meta-analysis. Although search criteria allowed inclusion of any functional 
gastrointestinal disorder, only papers describing trials of IBS of IBS-type symptoms 
were found and therefore the findings relate only to IBS. Results from the studies 
indicated that mindfulness-based therapies are effective at reducing IBS symptom 
severity and improving quality of life. They also suggested that improvements are 
maintained over the medium term. However the unclear or high risk of bias in many 
of the studies as assessed by the Cochrane risk of bias assessment led Aucoin et al. 
(2014) to recommend that the statistically significant effects “be interpreted with 
some discretion”. The seven studies also represented a range of mindfulness-based 
therapies making comparisons difficult.  This review therefore aimed to extend the 
findings of Aucoin et al. (2014) by answering the following three questions. 
1. What are the rationales for offering mindfulness-based therapies to 
individuals with IBS symptoms and how do the mindfulness-based therapies 
chosen reflect these? The reviewed studies all aimed to target the primary problems 
of IBS: symptom severity (abdominal pain/discomfort, alterations in bowel habit and 
bloating) and reduced health-related quality of life. Secondary problems of comorbid 
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depression and anxiety were included as co-analyses but the interventions were not 
designed specifically to target them. Although societal costs such as reduced 
productivity and loss of work days were widely cited as IBS-related issues, only one 
study measured the effect of mindfulness-based therapies on this. The studies 
differed in whether they hypothesised that the mindfulness-based intervention would 
impact on IBS by improving symptoms (which would then lead to an improvement 
in quality of life) or conversely would increase quality of life via greater acceptance 
of symptoms and reduced avoidance which would in turn improve symptoms 
themselves. Overall the studies provided little information on plausible mechanisms 
of why their mindfulness-based intervention would impact on IBS. Though several 
of the studies discussed the brain-gut axis, this was not linked clearly to the 
mindfulness interventions, or to possible causal mechanisms of action. The 
rationales given for offering mindfulness-based therapies either were not explicitly 
discussed, or merely cited observational findings of mindfulness-based therapies 
leading to improvement of symptoms and quality of life with similar health 
problems, rather than providing a specific theoretical basis for why mindfulness 
would lead to improvements in IBS. A variety of mindfulness-based approaches 
were used in the studies and it is not possible to conclude which choice of approach 
was most effective. Some studies adapted their protocols specifically for IBS 
populations whereas others used generic protocols but there was not sufficient data 
to establish superiority between approaches. Further research is warranted in this 
area. 
2. How do the study designs affect generalisability of findings? External 
validity was high in terms of Rome-criteria-diagnosed IBS and inclusion of various 
degrees of psychological disorder, but only one study was from a non-westernised 
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country. Similarly studies were well designed with measures to demonstrate the 
impact of mindfulness-based interventions on primary issues of symptoms severity 
and quality of life, but less well designed to enable conclusions about impact on 
health-economic factors. Choice of mood/stress measures varied widely but were 
mostly developed for use with medical populations (for the one measure used that 
was not, floor effects did not appear to occur in the data) and therefore there can be 
greater confidence in the data from those measures.  
Three studies used active control groups but only two reported efforts to 
achieve equivalence of interventions on nonspecific factors, and to provide 
credibility checks to control for expectation of benefit. Participant adherence to the 
interventions was inconsistently monitored and only one study was able to report 
data on a relationship between outcomes and adherence to the intervention. Zernicke 
et al. (2011) reported almost double the amount of improvement in IBS symptoms 
for those participants who attended a greater number of sessions. Similarly only one 
study reported monitoring therapists’ protocol adherence. This leaves some doubts 
about generalisability as, without knowing how closely participants’ experiences 
matched the stated protocols, we cannot know how well these interventions will 
translate to routine practice. If data existed which showed positive outcomes only 
resulted after close adherence to the specific elements of the protocol, rather than 
from general effects of attending a mindfulness-like intervention then this could aid 
the decision making of treatment providers. They would then be able to conclude 
whether their resources were warranted in being put into an intervention that closely 
matched the published protocols, or whether they could vary delivery substantially, 
and still expect positive outcomes. 
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3. Which conceptual issues should inform future trial designs?  
The influence of the placebo effect is one conceptual issue that should inform 
future trial designs. The three studies in this review that used active control groups, 
reported greater placebo responses than the studies utilising waitlist or TAU control 
groups. High levels of placebo response are common in IBS trials (Dorn et al., 2007; 
Patel et al., 2005; Su et al., 2004) suggesting a large influence of non-specific factors 
in improvement following interventions. Future trials which utilise sophisticated 
control group designs matching different elements of the active mindfulness 
intervention could demonstrate more clearly, which aspects of the placebo effect are 
the most efficacious and therefore warrant being prioritised in treatment protocols. 
Other conceptual issues including possible explanatory theories of IBS, the 
brain-gut axis and mechanisms of action of mindfulness-based therapies featured 
little in the reviewed studies. Dysregulation of the brain-gut axis can account for 
much of the observed symptoms of IBS (Mayer & Tillisch, 2011) and therefore 
future trials would benefit from being designed to be able to shed some light on 
whether the positive outcomes observed following mindfulness-based interventions 
were due to alterations of the brain gut axis, and the mechanisms of this. Current 
theories of the mechanisms by which mindfulness can influence the brain-gut axis 
proposes that mindfulness encouraging non-judgemental awareness of physical 
sensations, cognitions and emotions. This modulates the emotional components of 
pain processing, reduces catastrophic appraisals of the significance of 
gastrointestinal symptoms and reduces GI-specific anxiety (Garland et al., 2012).  
Efficacy of mindfulness-based therapies for IBS 
The meta-analysis conducted by Aucoin et al. (2014) concluded that 
mindfulness based-therapies for functional gastrointestinal disorders produced 
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medium effect sizes on both IBS severity and quality of life. Although the scope of 
this review did not include meta-analytic analysis of the papers, inspection of the 
data from the nine retrieved papers supported the conclusions of Aucoin et al. 
(2014). The search conducted for this review retrieved an additional paper to those 
identified by Aucoin et al. (2014) describing follow up results of an already 
published study (Gaylord et al., 2011). The additional data from this follow up paper 
added further evidence of the efficacy of mindfulness-based therapies on symptom 
severity and quality of life for individuals with IBS (Faurot et al., 2014) however 
effect sizes could not be calculated due to means only being reported and no standard 
deviations.  The only negative findings were reported in a sample of individuals in 
remission of IBD who either had high perceived stress levels or IBS symptoms; 
however subgroup analysis of only those with IBS symptoms did show improvement 
(Berrill et al, 2011). This suggests that there is a feature of IBS specifically which is 
amenable to mindfulness-based interventions (for example influencing attention to 
visceral stimuli), rather than there being a general impact on GI-related health. 
A meta-analysis of mindfulness-based therapies for somatisation disorders 
(Lakhan & Schofield, 2013) included three of the studies included in this review 
(Gaylord et al., 2011; Ljótsson 1 et al., 2010; Zernicke et al., 2013). They similarly 
concluded that mindfulness-based therapies for IBS showed medium effect sizes on 
symptom severity and quality of life although with only three studies (accounting for 
a combined sample size of 250) these results must be interpreted with caution. 
Concordance with literature on mindfulness-based therapies with other 
populations 
The positive results of mindfulness-based therapies with IBS concur with the 
existing literature on mindfulness-based therapies with other somatic conditions such 
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as fibromyalgia (Fjorback et al., 2013; Lakhan & Schofield, 2013), chronic pain 
(Baer, 2003; Chiesa & Serretti, 2011; Grossman et al., 2004; Reiner et al., 2013), 
cancer (Piet, Würtzen, & Zachariae, 2012; Shennan, Payne, & Fenlon, 2011; Smith, 
Richardson, Hoffman, & Pilkington, 2005) diabetes (Gregg, Callaghan, Hayes, & 
Glenn-Lawson, 2007; Hartmann et al., 2012), vascular disease (Abbott et al., 2014), 
Multiple Sclerosis (Simpson et al., 2014), breast cancer (Cramer, Lauche, Paul, & 
Dobos, 2012), prevention of recurrent depression relapse (Ma & Teasdale, 2004; 
Teasdale et al., 2000) and current depression or anxiety symptoms (Strauss, 
Cavanagh, Oliver, & Pettman, 2014). 
Clinical implications 
There are three main clinical implications that arise from this review; the first 
that mindfulness-based therapies show promise for positively impacting on severity 
of symptoms and health-related quality of life for individuals with IBS and should be 
made more widely available, the second that aspects of the placebo or ‘positive care’ 
effect should be harnessed in healthcare interactions for individuals with IBS, and 
thirdly that information about the brain-gut axis should be more readily explained to 
patients. 
The efficacy data for the effect of mindfulness-based interventions on IBS 
are only preliminary as they are based on a small number of papers and need 
replication, but are promising.  This suggests that mindfulness-based therapies 
should be made more widely available for individuals with IBS.  
There are also promising findings from the studies using an internet-based 
protocol (Ljótsson 1 et al., 2010; Ljótsson 2 et al., 2011; Ljótsson 3 et al., 2011; 
Ljótsson 4 et al., 2011) suggesting that wider provision of mindfulness-based 
therapies does not necessarily require large resources. However internet delivery 
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excludes many of the nonspecific effects which should ideally be harnessed. The 
protocol used in the Ljótsson studies provided some aspects of a positive patient-
practitioner relationship using telephone and messaging with practitioners.  Use of 
internet delivery to roll out provision of mindfulness-based therapies would need to 
be carefully considered for which populations it would be suitable for. In chronic 
pain studies very high attrition rates are seen with internet delivery methods (which 
could be a potentially harmful experience for the patient who then feels that they 
have failed) (Andersson, 2009; Macea, Gajos, Daglia Calil, & Fregni, 2010). 
However with highly motivated patients, and supportive practitioner relationships 
involved in other aspects of their care, there may be scope for such low-intensity 
interventions, but more research is needed on this issue. 
Tentative recommendations can also be made to focus on offering 
mindfulness-based interventions to patients with IBS on a self-referral basis to 
patients who have already received standard medical care and are still experiencing 
distressing symptoms, rather than offering it to all patients soon after diagnosis. This 
recommendation is based on findings from the Swedish research group. Using the 
same protocol in all three of their studies, much greater improvement were shown 
when participants chose to self-refer after seeing adverts for the programme 
(Ljotsson 1 et al., 2010) than when participants were approached at their first 
meeting with a gastroenterologist shortly after diagnosis (Ljotsson 3 et al., 2011). 
Another clinical implication concerns utilisation of the placebo effect. Many 
of the components of the placebo effect demonstrate aspects of the practitioner-
patient relationship that result in positive outcomes and as such can be considered a 
‘positive care effect’ (Blease, 2012). All practitioner-patient interactions will contain 
these aspects to differing extents and therefore efforts should be made to enhance the 
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key component as much as possible, both in psychological therapies and other 
healthcare appointments (Enck, Bingel, Schedlowski, & Rief, 2013). In practice this 
may involve close monitoring of outcomes and improvements (replicating the 
observer effect), taking time to explain the efficacy and mechanisms of any 
intervention and likely improvement (replicating expectations of improvement), 
allowing time during appointments to answer questions and address concerns 
(replicating attention) and linking patients into supportive IBS networks (replicating 
social support) (Enck et al., 2013).  
The third clinical implication involves explaining the role of the brain-gut 
axis in IBS to patients. Although this did not explicitly emerge from the studies 
included in this review, it is a recommendation based on taking an overview of the 
mechanisms of mindfulness-based therapies discussed in the papers. The function of 
the brain-gut axis in IBS is well documented (Mayer, 2011; Mulak & Bonaz, 2004; 
Tanaka et al., 2011; Tillisch et al., 2011) and intuitively experienced in the bodily 
experience during stress/fear. If patients were provided a clear explanation of the 
role of the brain-gut axis in IBS, it might serve to increase understanding on the 
‘functional’ nature of the disorder. It can be difficult for many patients diagnosed 
with functional disorders such as IBS that there is no identifiable physical or 
structural abnormality to account for their symptoms. This can lead some to feel that 
they are being told it is ‘all in their head’ or ‘not a real disease’ whereas their pain 
and distress is very real. Explanation of the brain-gut axis could help to provide a 
biological account of how their very real symptoms can occur without an observable 
organic disease. It could help to build an integrated mind-body model and perhaps 
reduce gastro-specific anxiety of symptoms and provide a rationale and motivation 
for engagement in psychological approached to IBS management. 
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Research implications 
Several research implications arising from this review have already been 
discussed above, and there are further recommendations which warrant discussion. 
The first is for further RCTs of mindfulness-based therapies for IBS with larger 
samples to increase the power of future meta-analyses and increase confidence in the 
promising results found. This would be aided by consistent use of measures across 
studies to measure symptom severity and mood/stress.  
It would be useful for future studies to collect data on treatment adherence, 
specifically amount of mindfulness practice completed between sessions and 
following the intervention. It would be expected that greater duration/frequency of 
practice would lead to greater/better maintained improvements and further data 
would allow conclusions to be drawn on the importance/unimportance of such 
extended practices. However this level of analysis would require large sample sizes 
in future studies. 
It would also be informative for future RCTs to compare and contrast 
different types of mindfulness-based therapies (for example MBSR vs. MBCT) or 
dismantling studies to investigate the relative influence of different components of 
interventions for example number of sessions, presence or absence of a mid-way 
retreat, use of a generic mindfulness protocol or one specifically designed for IBS. 
The currently reviewed studies represented a heterogeneous population of 
individuals with IBS both in terms of length of time since diagnosis and severity of 
symptoms (including patients in clinical remission from IBD). It would be important 
for future studies to investigate which subgroups of individuals with IBS would 
benefit most from mindfulness-based therapies; those newly diagnosed, or with a 
long history of IBS; only those that have not responded to other IBS treatments, or as 
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an adjunct to other successful treatments; and those with, or without comorbid 
psychological problems?  
It would be beneficial for future studies to investigate which factors 
contributed most strongly to the placebo response, and how they can be utilised to 
improve patient care in IBS. Whilst in experimental conditions these psychosocial 
factors may be discounted as ‘placebo’, their potency demonstrates that they should 
be enhanced in every patient-practitioner interaction. It would therefore be useful for 
future studies of mindfulness-based therapies with IBS to focus on how these 
psycho-social factors can be used to optimise efficacy of treatment.  
Limitations 
Several issues affect the interpretation of the findings from this review. 
Caution is needed when interpreting the findings from the study by Zomorodi et al. 
(2014). Published as an English translation of the original in Farsi, many sentences 
had ambiguous language. Their published protocol was very unclear, some data were 
not reported (end of intervention data was omitted and only follow up data reported) 
and they did not specify the origins of the measures they used. Despite these quality 
issues the study was included in this review as it was included in the Aucoin et al. 
(2014) meta-analysis that this review replicated and it was the only study 
representing a non-westernised sample. The N of the study was very small and so it 
is likely to have had only a minimal impact on the meta-analysis and it provided 
some indications that mindfulness-based interventions may have applicability 
beyond western-based populations. 
Another limitation is that a standard quality assessment tool was not used to 
rate the methodological quality of the included studies as this had already been 
reported in Aucoin et al. (2014) using the Cochrane risk of bias assessment and 
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CONSORT checklist for reporting trials of non-pharmacological treatment. This 
decision was taken as the focus of this review was on expanding the findings of the 
Aucoin et al. (2014) review in terms of design, methodological and theoretical issues 
rather than replicating their meta-analysis. 
Conclusions 
Mindfulness-based therapies for IBS show promising results on reducing 
symptom severity and improving health-related quality of life.  Data were 
insufficient to make recommendations on which mindfulness-based interventions are 
likely to be most effective or which subgroups of the IBS populations would benefit 
most (preliminary findings suggest self-referral to be more appropriate than being 
offered to all patients). Initial findings suggest that attendance of more than five 
sessions is associated with greater improvement but this finding is based on only one 
study and so needs replicating. Interesting questions were raised about the relative 
importance of non-specific (placebo) effects on the outcome of the interventions and 
more research is needed to explore this. 
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Abstract 
Aims. To evaluate whether a guided self-help mindfulness course reduced pain-
related distress and improved quality of life for inpatients with complex 
gastrointestinal pain and to investigate how useful and applicable participants 
experienced the course to be as well as the challenges and barriers they faced in 
taking part. 
Method. A mixed methods approach was used combining multiple single case 
design. Graphical analysis assessed changes in pain intensity and distress across 
multiple time points and pre-post analysis of changes in psychological distress, self-
efficacy, pain acceptance and mindfulness were analysed for reliable and clinically 
significant levels of change. Interviews before and after participation in the course 
were qualitatively analysed using thematic analysis. 
Results. Only four of the 15 participants completed the course within the time of the 
study. ‘Completers’ demonstrated reductions in pain distress over time as well as 
reliable and clinically significant change on most measures except for pain 
acceptance. The six participants who continued with the course described 
experiencing the course as useful, even when in intense pain. All participants 
described some challenges and the nine participants who discontinue the course 
described barriers to completing due to recurring illness, time taken up by pain and 
illness management and external distractions. 
Conclusions. Initial findings demonstrate the potential of using guided self-help 
mindfulness with inpatients. A briefer version of resources would increase its 
acceptability and further research could evaluate its potential with wider groups. The 
significant challenges and barriers facing patients with chronic and complex 
gastrointestinal pain require consideration of which inpatients will benefit most.  
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Introduction 
Chronic Pain 
Pain has been defined as “an unpleasant sensory and emotional experience 
associated with actual or potential tissue damage, or described in terms of such 
damage” (Merskey et al., 1979, p. 250). Chronic pain is commonly classed as any 
persistent non-cancer pain that persists for three months or more (Turk & Okifuji, 
2001). Many people are affected by chronic pain, with a recent survey reporting that 
it affects 31-37% of adults in the UK (The Heath and Social Care Information 
Centre, 2012), more commonly women and older age groups.  Available treatments 
are not wholly effective at eliminating chronic pain, leaving many people distressed 
and disabled (Turk, 2002). People with chronic pain often experience depression 
(Bair, Robinson, Katon, & Kroenke, 2003; Miller & Cano, 2009) and twice the rate 
of anxiety disorders compared to the healthy population (McWilliams, Cox, & Enns, 
2003). Pain is a subjective experience (Merskey et al., 1979). It cannot be measured 
directly, only through an individual’s self-report or behaviour (recently fMRI-
detected activation in certain brain areas are nearly as accurate as behaviour in 
assessing pain, although this is not yet clinically applicable) (Brodersen et al., 2012; 
J. E. Brown, Chatterjee, Younger, & Mackey, 2011).  
Pain experiences are best described using a biopsychosocial model which 
includes the influences of psychological and social factors (Gatchel, 2005) built on 
gate control theory (Melzack & Wall, 1965). The conscious experience of pain is 
built up from signals arising from the interplay between peripheral and visceral 
nociceptors (bottom-up processing) and central contextual and emotional 
information (top-down processing) (Turk & Gatchel, 2002). This means that pain is 
not purely a result of physical stimulation, but is heavily influenced by emotional 
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and other processing in the brain which can act to predispose someone to experience 
pain, amplify or suppress the severity of pain signals or perpetuate the experience of 
pain (Gatchel, Peng, Peters, Fuchs, & Turk, 2007). 
Many psychological processes can impact on sensations of pain: attention, 
interpretation and beliefs, as it is adaptive, from an evolutionary perspective, to use 
all possible information to make sense of a new pain, and previous experiences are 
important (Linton & Shaw, 2011). One of the functions of pain is to demand 
attention (Eccleston & Crombez, 1999) so that the individual mobilises escape and 
protective responses to minimise injury.  This can be modulated by other pressing 
demands on attention (for instance when survival is at stake) which can inhibit pain 
temporarily due to endogenous opioids (Lester & Fanselow, 1985). More often, 
attention is dominated by pain or by the expectation of pain (hypervigilance) 
(Eccleston & Crombez, 1999). Interpretation of pain also has an impact on 
processing, as demonstrated by the finding that patients with Irritable Bowel 
Syndrome (IBS) who believed that their symptoms were associated with serious 
pathology reported more intense symptoms and used fewer adaptive coping 
strategies (Drossman et al., 1999). Pain-related beliefs can be understood as 
providing shortcuts to interpretation, often drawing more on fears than on actual risk, 
which can then lead to unhelpful pain-related behaviours (e.g. “hurt is harm” leading 
to avoidance behaviours). Beliefs can also inform descending influences which 
amplify pain or fail to inhibit it (Crombez, Eccleston, Van Damme, Vlaeyen, & 
Karoly, 2012).  
Brain-gut axis and gastrointestinal pain 
Gastrointestinal pain encompasses any pain located in gut, intestines, colon 
or rectum. Processing of gastrointestinal pain differs from that of musculoskeletal 
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pain due to reciprocal processing between the enteric nervous system (ENS) and the 
central nervous system (CNS) named the brain-gut axis. The brain-gut axis describes 
a continuous feedback loop between sensory neurons of the ENS (including the gut, 
intestines, colon and rectum) and motor responses generated in the CNS (Burnett, 
C.K., & Drossman, 2004). Nerve signals from the ENS differ from those from our 
skin, for example, as they do not usually enter conscious perception, but are part of 
the autonomic nervous system, and are generated by different stimuli (torsion, 
stretch and distension) rather than by high levels of heat, cold or pressure. However 
in certain circumstances, changes to the brain-gut axis lead to hypersensitivity so that 
normally unperceived signals from the gut become perceived as pain or discomfort 
which is posited to be one of the explanations for the experience of pain without 
observable tissue damage in Functional Gastrointestinal Disorders (FGIDs) (Mayer 
& Tillisch, 2011). 
Psychological interventions with pain 
As psychological factors are an important component of the experience of 
pain, intervening at the psychological level should have the potential to improve an 
individual’s experience of pain. The psychological intervention most widely 
investigated for effectiveness in pain management is Cognitive Behavioural Therapy 
(CBT). 
CBT. The CBT approach to chronic pain management includes both 
behavioural and cognitive components. The behavioural components focus on 
identifying and changing unhelpful pain-related behaviours (such as restricting 
activity to avoid or minimise pain) which can otherwise exacerbate the pain problem 
through further physical deterioration and lack of opportunity for positive 
experiences. The cognitive components focus on challenging unhelpful beliefs about 
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pain and styles of processing pain-related thoughts such as catastrophizing. A recent 
Cochrane meta-analysis found there was evidence for CBT having a small beneficial 
effect on improving pain, minimal effects on improving disability but larger effects 
in improving mood (Williams, Eccleston, & Morley, 2012). 
Mindfulness interventions for chronic pain. As previously described, 
emotional reactivity to pain can increase the distress it causes (Gatchel et al., 2007). 
Mindfulness based approaches aim to reduce this distress by increasing acceptance 
(not resignation) towards chronic pain and thereby reducing unhelpful attempts to 
avoid or control pain when that is not possible. The individual can then focus on 
other experiences in the environment and their own valued activities (Burch & 
Penman, 2013). 
Mindfulness has been described as focussing attention on the experiences of 
the current moment in an open, curious and accepting way, without judging or 
reacting to them (Kabat-Zinn, 1990). It is a skill inherent in all humans, but 
individuals possess it to a greater or lesser degree (K. W. Brown & Ryan, 2003). 
Origins. Mindfulness practices originated in Eastern traditions including 
Buddhism over 2000 years ago. Western cultures began to adopt the central 
principles of present-moment awareness and non-judgement of experiences more 
widely in the 1970s.  
Structured mindfulness programmes. The first use of mindfulness practices 
in a structured way were described by Jon Kabat-Zinn who developed Mindfulness 
Based Stress Reduction (MBSR) (Kabat-Zinn, Lipworth, Burney, & Sellers, 1986). 
MBSR was developed for individuals with chronic health problems (most 
experienced pain) and aimed to help them cope more effectively with their distress. 
Group participants attended two and a half hour sessions weekly for eight weeks, a 
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full day retreat between weeks six and seven and were encouraged to practise for a 
minimum of 45 minutes personal meditation daily at home. Three main techniques 
were taught in the MBSR programme. The ‘body scan’ meditation instructs the 
individual to sequentially focus their attention on different areas of their body, trying 
to notice any sensations as purely and uncritically as they can, without adding 
judgements or labels. The ‘sitting meditation’ instructs individuals to focus 
mindfully on the physical sensations of breathing, and to try to bring non-
judgemental awareness to the natural stream of consciousness that all individuals 
continuously experience. ‘Hatha yoga’ practices comprise the final elements 
involving gentle stretches, breathing exercises and encouragement of postures that 
strengthen and relax the body. 
A second widespread structured mindfulness programme was later developed 
by Mark Williams and others in the UK for recovered recurrently depressed patients 
to prevent depressive relapse (Segal, Williams, & Teasdale, 2002). This approach 
combined mindfulness practices with techniques from CBT to form Mindfulness 
Based Cognitive Therapy (MBCT). Being based on earlier MBSR it shared many 
features, with similar length and duration of the programme and similar meditations 
including ‘the body scan’, ‘mindful movement’ and different length ‘sitting 
meditations’. 
Efficacy of mindfulness programmes. Early studies of MBSR with 
outpatients reported positive improvements both for pain ratings and physical 
symptoms (Kabat-Zinn, Lipworth, & Burney, 1985), which were maintained four 
years later for physical and psychological symptom improvement (Kabat-Zinn et al., 
1986). Recent neuroimaging studies showed changes in brain regions related to pain-
80 
processing in individuals after repeated mindfulness practice (Zeidan et al., 2011) 
suggesting mindfulness has an effect at a neural level. 
Meta-analyses of mindfulness-based interventions report reductions in pain 
intensity with effect sizes around 0.5 (Baer, 2003; Grossman, Niemann, Schmidt, & 
Walach, 2004; Reiner, Tibi, & Lipsitz, 2013). Another meta-analysis with more 
stringent measures of inclusion criteria reported a lack of evidence for direct effects 
of mindfulness on reducing pain intensity but strong evidence for non-specific 
effects on reduction of pain symptoms, improvement of depressive symptoms and 
improvements in coping with pain (Chiesa & Serretti, 2011). The majority of studies 
into the use of mindfulness with chronic pain patients have focussed on 
musculoskeletal pain. However, two systematic reviews have reported on the 
efficacy of mindfulness-based interventions in improving gastrointestinal pain and 
related symptoms of Irritable Bowel Syndrome (IBS) and Functional Gastrointestinal 
Disorders (FGIDs) (Aucoin, Lalonde-Parsi, & Cooley, 2014; Lakhan & Schofield, 
2013). 
Both MBSR and MBCT are designed to be delivered to groups of 
participants in outpatient settings and therefore represent patients well enough to 
travel and commit to an eight week group. However many individuals with chronic 
pain may be unable to attend such a structured programme due to unpredictability of 
their health status, frequent hospital admissions and access issues. A method of 
delivery which could be more flexible may therefore be beneficial. One study 
demonstrated the feasibility of providing mindfulness instruction via audio tapes to 
individuals receiving chemotherapy for cancer and found positive outcomes on 
measures of mood and quality of life (Altschuler, Rosenbaum, Gordon, Canales, & 
Avins, 2012).  
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Chronic pain in inpatient settings 
A recent national patient survey of 64,000 people admitted to NHS hospitals 
reported good pain management to be one of the highest concerns of patients, and 
satisfaction with pain control was below expected standards (Care Quality 
Commission, 2012). Provision of pain services to inpatients relies largely on 
analgesic pain management and most formal psychological interventions are only 
available to outpatients. To date there have not been any published accounts of 
attempts to provide a mindfulness programme flexibly to inpatients which can then 
be continued following discharge home. 
Gastrointestinal pain in inpatient settings. Chronic gastrointestinal pain 
can be extremely difficult to manage with traditional analgesia as the common side 
effects of the most potent analgesics (opioids) can severely affect gastrointestinal 
functioning. Many individuals with chronic gastrointestinal pain are often unable to 
tolerate stronger painkillers and therefore have to cope with high levels of residual 
pain. Individuals with gastrointestinal pain are also likely to require frequent lengthy 
hospital admissions due to difficulties with feeding and nutrition (many are fed either 
directly by a tube into their gut or into their veins) and consequently frequent 
infections. They represent a severe and complex subset of hospital patients who may 
experience many more frequent and extended hospitalisations. When not 
hospitalised, multiple outpatient hospital appointments and extended daily health 
regimens take up significant portions of individuals’ time and energy. These patients 
therefore differ from those recruited to most existing studies of mindfulness for ill 
health or chronic pain who are usually at a more stable period in their illness and 
able to attend outpatient mindfulness groups regularly. Although this poses 
significant challenges to participation, this group is a subset of chronic pain patients 
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who may benefit most from having access to a mindfulness-based intervention 
within the hospital setting, as they may find it very difficult to attend outpatient 
groups. 
Research questions 
The aims of this study therefore are to assess the feasibility of providing a 
mindfulness-based intervention to inpatients with gastrointestinal pain and answer 
the following hypotheses: 
1. Can an individual mindfulness intervention for inpatients with 
gastrointestinal pain reduce pain-related distress, improve quality of life, and 
increase confidence in pain self-management? 
2. How useful and applicable do inpatients with gastrointestinal pain find 
MBSR methods? 
 
Methods 
Setting 
The study took place across two specialist wards at an inner city University 
teaching hospital admitting patients with chronic and complex gastrointestinal pain. 
The primary ward specialised in patients with “gastrointestinal failure” and often 
admitted patients for lengthy hospital stays with an average duration of six weeks, 
with some lasting for several months. Another doctoral study investigating staff 
attitudes towards pain management occurred during the same time period. 
Participants 
Participants for the study were patients admitted to the two identified wards 
between August 2014 and February 2015 who were experiencing long-term 
83 
gastrointestinal pain as well as many comorbid difficulties including infections and 
feeding difficulties. 
Inclusion and exclusion criteria. Inclusion criteria were: age 18 years or 
older, gastrointestinal pain experienced for more than three months, and able to 
understand English. Exclusion criteria were: previous experience of a mindfulness 
programme, severe cognitive impairment, or profound hearing difficulties. 
Ethical approval. Ethical approval was obtained from the National Research Ethics 
Service Committee London - City Road and Hampstead on 1st July 2014 (Appendix 
1). 
Procedure 
Recruitment. Recruitment took place between August 2014 and February 
2015. In August 2014 the researcher met with nursing staff on the wards to discuss 
the rationale for the study and agree on a protocol for recruitment. Potential 
participants were identified by senior nursing staff on each of the wards and 
discussed with the researcher weekly. If the participants met the inclusion criteria 
then nursing staff would approach the patient, describe the study, offer a patient 
information sheet, and ask for verbal consent for the patient to be visited by the 
researcher. The researcher met with the patient to discuss the study further and 
confirm that the eligibility criteria were met and answer any questions. Participants 
were given a minimum of 24 hours to consider taking part in the study before the 
researcher returned to obtain written consent. 
Data collection. Participants who consented to take part completed initial 
baseline measures in person with the researcher and recorded an interview about 
their chronic pain. Pain intensity, distress and qualitative feedback on the 
intervention was recorded following completion of each section of the eight-part 
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mindfulness course either in person if the participant remained in hospital, or by 
telephone if they had been discharged home. Following completion of the 
programme participants repeated the initial baseline measures and recorded a further 
interview about their chronic pain and experience of the mindfulness programme 
either in person or by telephone. Participants who did not complete the programme 
recorded an interview about their experience of the programme, their decision not to 
complete it and the challenges and barriers they faced when trying to follow the 
programme. All data and audio files were stored securely on password-protected, 
university computers. 
Mindfulness programme. The treatment intervention consisted of a 
published self-taught mindfulness programme ‘Mindfulness for Health: A practical 
guide to relieving pain, reducing stress and restoring wellbeing’ (Burch & Penman, 
2013), guided and supported by the researcher. This programme was selected as the 
treatment programme had been demonstrated to have positive results on mental 
wellbeing and coping with pain when delivered in a group format (C. A. Brown & 
Jones, 2013; Cusens, Duggan, Thorne, & Burch, 2010).  
The materials consisted of a book which provided background information 
on mindfulness, chronic pain and the scientific basis and rationale for using a 
mindfulness approach with chronic pain, as well as providing many personal 
vignettes of individual’s experiences of chronic pain and mindfulness. The rationale 
for choosing this book included the accessible nature of its content which 
presupposed no existing knowledge of mindfulness techniques. It was also one of the 
few widely available self-directed mindfulness programmes specifically intended for 
chronic pain populations rather than general populations. It therefore took into 
account necessary adaptations readers with chronic pain may need to make to their 
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mindfulness practice. Following the preliminary background chapters, the book is 
split into eight parts introducing a new element of the programme in each section 
accompanied by a new mindfulness meditation (audio recorded and provided to the 
participants on an mp3 player). As well as introducing the new meditation, each 
section also discusses the rationale for each type of meditation, provides personal 
examples of previous users benefitting from the practices, and recommends 
additional ‘habit releaser’ activities to further develop mindfulness skills e.g. 
spending time with nature or using mindfulness when making a hot drink. Later 
sections also introduced ideas around pacing activities including self-monitoring. 
Participants were encouraged by the researcher in weekly contacts to progress 
through the sections of the programme weekly and to listen to specified mindfulness 
meditation a minimum of once daily.  
Design 
The design of a study should be chosen that best answers the research 
questions proposed (Barker, Pistrang, & Elliott, 2002). This study posed two 
research questions, with each being suitable for a different approach and so a mixed-
methods design was chosen incorporating both quantitative and qualitative methods. 
The quantitative data would be used to assess the efficacy of the intervention, and 
the qualitative data would be used to assess usefulness and applicability of the 
intervention. This follows a ‘partially mixed concurrent equal status design’ (Leech 
& Onwuegbuzie, 2009), as the two methods of data collection are undertaken 
concurrently and each method is given equal status. Due to the sparseness of existing 
literature and research with this population, this was designed as an exploratory 
study. A multiple single case design was chosen to address the first research 
question, with repeated measures collected from each participant as s/he progressed 
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through the programme. Due to the complex nature and variety of conditions the 
participants experienced, multiple external factors could have impacted on the 
quantitative outcome of the programme and so each participant acted as his/her own 
control. In order to address the second research question, a qualitative approach was 
chosen to be able to reflect the richness and individual nature of the data from each 
participant. 
Measures 
Time points at which each measure was taken is shown in Table 1. 
Table 1  
Measurement time points 
Time point Measures administrated 
Baseline PI, PD, HADS, PSEQ, CPAQ, FFMQ, PrePI 
Programme PI, PD, FMP, WQF 
End point PI, PD, HADS, PSEQ, CPAQ, FFMQ, PostPI/DOI 
Note: PI=Pain Intensity Rating; PD= Pain Distress Rating; HADS= Hospital Anxiety and 
Depression Scale; PSEQ=Pain Self Efficacy Questionnaire; CPAQ=Chronic Pain Acceptance 
Questionnaire; FFMQ=Five Factor Mindfulness Questionnaire; FMP=Frequency of Mindfulness 
Practice; WQF=Weekly Qualitative Feedback; PreP=Pre-Programme Interview; PostPI/DOI= Post-
Programme Interview/Drop Out Interview. 
 
Pain intensity and pain distress. A Numerical Rating Scale (NRS) was used 
which asked participants to rate their pain on an 11 point scale (from 0 to 10) which 
asked “how intense is the pain on average in the last week” with 0 being anchored 
with a label of “no pain” and 10 being anchored with the label “extreme pain”. 
Participants either circled the appropriate number on the numbered line using pen 
and paper, or verbally reported it to the researcher who recorded it. A similar NRS 
was used for pain distress ratings, also on an 11 point scale (from 0 to 10) which 
87 
asked: “how distressing is the pain on average in the last week”. The scale was 
anchored with 0 being labelled “not distressing at all” and 10 being anchored with 
the label “extremely distressing”. Again participants circled the appropriate number 
using pen and paper, or verbally reported it to a researcher who recorded it. Eleven 
point NRS have been found to be equally reliable and valid for pain ratings as Visual 
Analogue Scales (VAS), 101 point numerical rating scales and 11 point box scales 
for both chronic and acute pain (Jensen, Karoly, & Braver, 1986; Jensen, Karoly, 
O’Riordan, Bland, & Burns, 1989). A NRS was chosen as studies have found it is 
preferred by individuals over a VAS (Price, Patel, Robinson, & Staud, 2008). 
Internal consistency cannot be used for these measures as they are single item 
measures. Zautra, Johnson, and Davis (2005) reported a two-week test-retest 
reliability of .69 for pain intensity on a 101 point NRS, no estimates of reliability for 
pain distress were found and so a .69 estimate of reliability was adopted following 
the same adoption by Morley, Williams and Hussain (2008). 
Frequency of mindfulness practice. The frequency with which participants 
listened to the mindfulness meditations was recorded for each section of the 
programme completed, as a measure of programme adherence. This was entered on 
to the ‘weekly feedback sheet’ (Appendix 2) by circling the appropriate number for 
frequency and writing the average length of each practice. 
Weekly qualitative feedback. The ‘weekly feedback sheet’ ended with three 
questions inviting participants to provide qualitative feedback, the first about the 
pain: “this week, how did the pain make you feel emotionally”, and the others 
inviting reflection on the mindfulness programme: “what went well” and “what 
didn’t go well”. Participants either wrote their responses on the sheets or answered 
verbally, their responses recorded verbatim by the researcher. 
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Psychological distress. The Hospital Anxiety and Depression Scale (HADS) 
(Zigmond & Snaith, 1983) is a 14 item questionnaire composed of two seven-item 
subscales, the HADS-A and HADS-D, intended to measure levels of anxiety or 
depression. This was selected in preference to other measures of anxiety and 
depression as it does not contain items capturing somatic elements of distress which 
would otherwise be likely to inflate scores in a chronic pain sample. For each of the 
14 statements respondents are requested to indicate which of four verbal descriptions 
best fits the truthfulness of that statement for them. Although many studies have 
confirmed the two-factor structure (Bjelland, Dahl, Haug, & Neckelmann, 2002) a 
recent review of 50 studies found only half confirmed a two factor structure and 
concluded that the HADS is more suitable to provide a single measure of distress 
(Cosco, Doyle, Ward, & McGee, 2012). It has shown good psychometric properties 
within health populations with a test-retest reliability of r=.72 and Cronbach’s α=.89-
.93 (Zigmond & Snaith, 1983) and good convergent validity with correlations 
between the HADS and other questionnaires of psychological distress ranging from 
.49 to .83 (Bjelland et al., 2002). 
Self-efficacy. The Pain Self Efficacy Questionnaire (PSEQ) (Nicholas, 1989) 
is a 10 item scale that attempts to capture a measure of an individual’s confidence in 
being able to perform specific behaviours despite pain, rated on a numerical scale 
from 0 “not at all confident” to 6 “completely confident”. Scores range from 0 to 60 
with higher scores representing stronger self-efficacy beliefs. The PSEQ has been 
shown to have good test-retest reliability and a high internal consistency (Cronbach’s 
α=.92), and validity (Nicholas, 2007). 
Acceptance. The Chronic Pain Acceptance Questionnaire (CPAQ) 
(McCracken, Vowles, & Eccleston, 2004) is a 20 item measure included to provide a 
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rating of acceptance of pain. It was adapted through factor analysis from an original 
version (Geiser, 1992) resulting in two factors (Pain Willingness and Activity 
Engagement). Factor stability and construct validity has been demonstrated 
(McCracken et al., 2004) as well as good internal consistency (Cronbach’s α 
between 0.79 and 0.87) (Nicholas & Asghari, 2006). 
Mindfulness. The Five Facet Mindfulness Questionnaire (FFMQ) (Baer, 
Smith, Hopkins, Krietemeyer, & Toney, 2006) is a 39 item questionnaire which has 
been developed from five mindfulness questionnaires using exploratory factor 
analysis. It proposes five facets: Observe, Describe, Nonjudging of Inner Experience, 
Acting with Awareness, and Nonreactivity to Inner Experience, that together form a 
single second-order factor: overall mindfulness. The FFMQ has been shown to have 
good internal consistency (Cronbach’s α between 0.72 and 0.92) and good construct 
validity (Baer et al., 2008). 
Interviews. 
Pre-programme interview. Before starting the mindfulness programme, all 
participants were interviewed regarding their chronic pain and expectations of the 
programme. The interview schedule was developed to encourage participants’ 
reflections on the current status of their chronic pain, how they related to it and how 
they visualised it (Appendix 3). The schedules were used as a guide to the interview 
and alternative or follow-up questions used where appropriate. 
Post-programme interview. All participants who completed the mindfulness 
programme were again interviewed using the interview schedule from the pre-
programme interview. This was chosen to enable comparisons of participants’ 
descriptions of their pain, relationship to pain and visualisation of pain. An 
additional interview schedule was developed based on elements of the Change 
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Interview (Elliott, Slatick, & Urman, 2001), including questions exploring change 
and attributions of changes as well as questions focussed on gathering experiential 
data of the programme and thoughts of usefulness/applicability of the programme 
(Appendix 4). 
Drop-out interview. Participants who were unable to complete the 
mindfulness programme were interviewed to ascertain their reasons for dropping out, 
any challenges or barriers that led them to drop out, and whether they recommended 
any adaptations to the programme (Appendix 5). 
Analysis 
Quantitative analysis. All quantitative data were entered into statistical 
analysis software (IBM SPSS Statistics version 22). Repeated weekly measures were 
displayed graphically following guidelines by Morley and Adams (1991) and 
analysed visually. Pre/post questionnaire data were analysed for each individual for 
both reliable change and clinically significant change (Jacobson & Truax, 1991). 
Reliable change describes changes in individuals’ scores that are large enough to not 
merely be due to measurement error. Clinically significant change describes changes 
in individuals’ scores that both show reliable change and change of magnitude that is 
clinically relevant (and not trivial). Clinical significance can be defined as moving 
outside the range of scores of a clinical population (criterion a) or within the range of 
scores of a normative population (criterion c) or halfway between (criterion b). 
Reliable change criteria were calculated for each measure using published reliability 
coefficients. As there are no available statistics representing a normative population, 
means and standard deviations from relevant clinical populations were used (see 
Table 2). Following Jacobson and Truax (1991), criterion a was used for clinical 
significance (participant’s scores needed to move to beyond 1.96 standard deviations 
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from the clinical norm to be classified as clinically significant change). Data were 
entered into a Microsoft Excel calculator to compute statistics and generate graphs 
(Morley & Dowzer, 2014). For ratings of pain intensity and pain distress, reliability 
estimates were not used as these rely on an assumption that pain scores will remain 
stable over time and so any variation is due to error. In chronic pain however, it is 
expected that pain will vary over time, particularly in the two-week window used for 
test-retest reliability estimates. Therefore the criteria for clinically significant change 
was a 30% reduction in pain scores from baseline, a degree of change considered  
clinically relevant within chronic pain populations (Dworkin et al., 2005).  
 
Qualitative Analysis. A pragmatic approach was adopted towards qualitative 
analysis and the methods chosen to best answer the second research question 
Table 2 
Reliable change statistics for all measures 
Measure Published clinical 
population 
Clinical 
population 
mean 
Clinical 
population 
SD 
Reliability 
coefficient 
HADS (Morley, Williams & 
Hussain, 2008) 
 
20.85 7.2 α=.89-.93 
PSEQ (Morley, Williams & 
Hussain, 2008) 
 
22.66 10.56 α=.92 
CPAQ (McCracken et al., 
2004) 
 
70.5 19.0 α=.79 
FFMQ (Schütze, Rees, Preece, 
& Schütze, 2010) 
125.08 31.43 α=.78 
HADS= Hospital Anxiety and Depression Scale, PSEQ= Pain Self-Efficacy Questionnaire, 
CPAQ= Chronic Pain Acceptance Questionnaire, FFMQ= Five Factor Mindfulness Questionnaire 
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(Pistrang & Barker, 2012). As the study was a feasibility project trialling 
mindfulness with an inpatient gastrointestinal pain population for the first time, the 
qualitative data were collected to enable evaluation of the programme, 
recommendations for adaptions before expanding the intervention more widely 
across the hospital, and to gain insight into participants’ experiences of the course. 
The interview schedule used for data collection therefore focused on specific aspects 
of participants’ experiences rather than an overview of their experience. Thematic 
Analysis (TA) was selected to analyse the data. TA is a systematic and transparent 
method of qualitative analysis which enables patterns of meaning to be identified and 
analysed in a data set (Joffe, 2012).  
TA is a flexible qualitative method suitable for research from different 
epistemological positions (Braun & Clarke, 2006). A critical realist stance was 
adopted for this research which assumed that although data can tell us more about 
reality, interpretation is necessary to access the underlying structures (Willig, 2013). 
Therefore a degree of subjectivity is inherent in the creation of knowledge (Madill, 
Jordan, & Shirley, 2000). This position was suited to the analysis of participant 
transcripts to identify and contextualise the reality of their experience engaging with 
the mindfulness programme, which are also likely shaped by particular contexts and 
understandings such as the role of being a patient and living with a chronic illness.  
TA was selected for its flexibility in allowing both an inductive (bottom-up 
approach led by the content of the data) and a deductive (top-down approach which 
uses ideas or topics brought by the researcher to interpret the data) approach to 
analysis (Braun & Clarke, 2012). A primarily deductive approach was used in order 
to address the second research question. Transcripts were analysed according to three 
domains which reflected the questions asked at interview: hopes and expectations of 
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the mindfulness course, positive and negative aspects of the course, and challenges, 
barriers and suggestions for improvements. This approach was chosen as the primary 
aim of the qualitative analysis was to gain evaluative data on the programme to 
inform future use and focussed primarily on the manifest content of the data.  
The six stage procedure described by Braun and Clarke (2006) was followed. 
All recordings of pre and post interviews were transcribed verbatim and any personal 
identifiable information removed, and all written weekly feedback was typed and 
collated. This was performed by the researcher to help facilitate early familiarisation 
with the data. All data items were re-read and initial comments annotated on the 
transcripts. On the following reading of the data, initial codes were noted as any 
items of text which appeared to describe (either explicitly or latently) an idea or 
concept relevant to the research question. A code refers to the “most basic segment 
or element of the raw data” (Braun & Clark, 2006, p.19). Themes were then 
constructed from these initial codes by clustering together codes which the 
researcher interpreted to be linked conceptually. This led to an initial thematic map. 
The entire data set was then re-read to review the initial tentative themes against the 
raw data and any recoding/changes to themes made, to try and ensure the themes 
were heterogeneous and that the codes within the themes were homogenous. Once 
the amended thematic map closely fit the data in terms of adequately describing the 
elements of the research question apparent in the data, themes were defined and 
named and extracts of raw data selected which clearly illustrate incidences of the 
themes in participants’ responses.  
The researcher kept an awareness that she was an active agent in the research 
process (Braun & Clarke, 2012), and constructed themes from the available data so 
personal ideas and assumptions would necessarily impact on the analysis. Therefore 
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prior to data analysis and throughout coding the researcher made notes of their 
implicit assumptions and thoughts on the data to help clarify any biases in 
interpretation. An example transcript was independently coded by a peer researcher 
and any differences in coding were discussed and code/theme definitions more 
accurately defined. 
Personal context 
I am a 26 year old heterosexual white British woman and I have lived in 
England all my life. I am a Trainee Clinical Psychologist at UCL and have worked in 
the area of mental health for six years, with two six month placements in Health 
Psychology settings. I have always been in good health and have never experienced 
chronic pain, and therefore will have a different lens of interpretation on the data 
than someone with a personal experience of chronic pain or chronic illness.  My 
experiences of inpatient hospital settings are predominantly in a professional context 
rather than as a patient or relative and so my understanding of patient-health 
professional interactions will similarly be influenced by this context.  
 
Results 
Participant recruitment took place between August 2014 and March 2015. 
The two identified gastrointestinal failure wards comprised 90 patient beds. Across 
the eight month recruitment period 68 potential participants were identified through 
discussions with nursing and medical staff. Of these, 17 did not meet inclusion 
criteria, 23 declined to participate and 13 were discharged from the ward before 
consent could be gained. In total 15 participants gave written consent and completed 
baseline measures.  
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Participant characteristics 
Of the 15 participants who took part 73% were female and 80% were white 
British. The mean age of the sample was 32.3 (SD =9.9; range 21-52; median 29 
years) and the average years of education was 13.5 (SD= 2.3; range 10-19; median 
13 years). The primary diagnoses related to gastrointestinal pain were Crohn’s 
disease (20%), ulcerative colitis (7%), gastroparesis (20%), and pancreatitis (7%). 
No diagnosis had been proposed for two participants (13%). The median time since 
onset of chronic pain was seven years. All were prescribed medication for pain and 
the majority were prescribed opioids (87%). Half the participants reported current 
diagnoses of depression (47%) and a third were prescribed antidepressants. 
Attrition 
Only one participant remained on the ward for the full duration of the 
mindfulness course. Due to the complex nature of the health difficulties participants 
faced, many found they were unable to complete the course. Three participants were 
discharged shortly after entering the study and dropped out before completing week 
one of the course. For one participant (P8), his chronic pain stopped shortly after 
discharge from hospital after successful surgery and so he did not begin the course. 
P2 was unable to engage with the mindfulness course since she became very unwell 
during transfer home and was readmitted to her local hospital for several weeks, 
while her father was diagnosed with cancer. P9 dropped out before completing week 
one as she found it very difficult to cope with how unwell she felt once discharged 
home and was readmitted to hospital several times.  
Of the 12 participants who began the mindfulness course, half dropped out 
before completion. For three participants this was due to illness and frequent 
readmissions to hospital (P6 after four months trying to complete the first two 
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weeks; P12 after three months completing half of the course; P15 after three months 
completing week one). A further two participants dropped out part way through, 
reporting that they were not finding the course helpful (P10 after two months 
completing half of the course; P14 after two months completing three weeks). 
Another participant (P11) completed week one while an inpatient, but on discharge 
was unable to continue as her daughter became suddenly unwell and needed frequent 
visits to specialist hospitals. T-tests demonstrated no statistical differences at 
baseline on any measure between the six participants who continued with the course 
and the nine who either did not start or dropped out (see Appendix 6). 
Of the six participants who continued with the course, only four were able to 
complete it within the time frame of the study. Most participants found it very 
difficult to complete each weekly section of the course within seven days because of 
unexpected illness and extended periods of time attending outpatient appointments, 
completing their daily health regimes and other external pressures on their time and 
energy. Therefore two participants were still continuing with the course when data 
collection ended (P7 after six months had progressed through five weeks; P13 after 
three months had progressed through one week). This resulted in four participants 
completing all eight weeks of the mindfulness course.  
Figure 1 displays the flow of participants through the study including attrition 
rates at each stage and the final data available for analysis. Of the 13 participants for 
whom ending measures were available and an end interview conducted: four were 
‘completers’, two were ‘incomplete’, four were ‘drop-outs’ and three were ‘non-
starters’. The two missing data were both ‘dropouts’ who were uncontactable.  
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Figure 1. Participant flow 
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(n= 15) 
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(n=68) 
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(n=12) 
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end interview 
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end interview 
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Quantitative analysis 
The quantitative data were analysed to address the first research question: can 
an individual mindfulness intervention for inpatients with gastrointestinal pain 
reduce pain-related distress, improve quality of life, and increase confidence in pain 
self-management? Group level statistical analyses of baseline-endpoint measures 
were not possible as the small sample size meant that there was not enough power to 
detect an effect (risk of type II error too high). Statistical analysis of baseline-
endpoint data was calculated per participant using reliable change and clinically 
significant change criteria, so that each participant acted as his/her own control. 
Reliable change index (RCI) and clinically significant change (CSC). 
Table 3 and Figure 2-5 show the ‘completer’ group participants’ mean scores for 
each measure at baseline and endpoint (pain intensity and pain distress were also 
measured weekly and are discussed separately). The RCI for each measure was 
calculated and where the observed change from baseline to endpoint was greater than 
the RCI (and therefore unlikely to be due to measurement error) is indicated in Table 
3. CSC criteria were also calculated and where these criteria are met are indicated in 
Table 3. Of the 24 baseline-endpoint observations, 14 met CSC criteria. Due to a 
statistical quirk, no participants demonstrated reliable change that was not also 
clinically significant, in part due to the stringent measures of RCI, which, given the 
large SD in the samples, required a substantial baseline-endpoint change to meet the 
reliable change criteria, and therefore were also large enough to meet the CSC 
criteria. RCI for pain ratings were not calculated and clinical significance defined as 
a reduction in pain scores from baseline of >30%. 
Weekly pain ratings. Assessing change between baseline and endpoint only 
captures an overall change and cannot describe the trajectory of change for 
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participants. Ratings of pain intensity and pain distress were collected following 
completion of each week of the course and are represented graphically for each 
participant who completed four or more weeks of the course (see Figure 6 and 7). 
Pain intensity ratings were not intended as a primary outcome measure of this 
study as mindfulness does not aim to reduce pain itself (although this sometimes 
occurs) but aims to reduce the distress that pain causes. However, pain intensity 
scores were collected as the context of pain distress ratings and because it may have 
helped participants to distinguish the two in their ratings.  
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Table 3 
Mean scores for each participant who completed the mindfulness course at 
baseline and endpoint with reliable change and clinically significant change 
interpretation 
Measure P1 P3 P4 P5 
Pain intensity 
Baseline 
Endpoint 
RCI 
 
10 
0 
 CSC 
 
6 
5 
NC 
 
8 
7 
NC 
 
6 
0 
CSC 
Pain distress 
Baseline 
Endpoint 
RCI 
 
10 
0 
CSC 
 
6 
4 
CSC 
 
7 
5 
CSC 
 
5 
0 
CSC 
HADS 
Baseline 
Endpoint 
RCI 
 
22 
6 
RC, CSC 
 
17 
11 
RC, CSC 
 
20 
16 
NC 
 
6 
8 
NC 
PSEQ 
Baseline 
Endpoint 
RCI 
 
12 
33 
RC, CSC 
 
16 
27 
RC, CSC 
 
15 
30 
RC, CSC 
 
41 
33 
NC 
CPAQ 
Baseline 
Endpoint 
RCI 
 
17 
35 
NC 
 
53 
60 
NC 
 
46 
60 
NC 
 
64 
72 
NC 
FFMQ 
Baseline 
Endpoint 
RCI 
 
118 
144 
RC, CSC 
 
120 
135 
RC, CSC 
 
112 
134 
RC, CSC 
 
138 
140 
NC 
HADS= Hospital Anxiety and Depression Scale; PSEQ= Pain Self Efficacy Questionnaire; 
CPAQ= Chronic Pain Acceptance Questionnaire; FFMQ= Five Factor Mindfulness Questionnaire; 
RCI= Reliable Change Index; RC= Reliable Change at the 95% confidence interval; CSC= 
Clinically Significant Change; NC= No Change. 
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Figure 3 Plot of PSEQ scores pre and post treatment for completer group, with 
reliable change margins and clinical cut offs demonstrated 
Figure 2 Plot of HADS scores pre and post treatment for completer group, with 
reliable change margins and clinical cut offs demonstrated 
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Figure 5 Plot of FFMQ scores pre and post treatment for completer group, with 
reliable change margins and clinical cut offs demonstrated 
Figure 4 Plot of CPAQ scores pre and post treatment for completer group, with 
reliable change margins and clinical cut offs demonstrated 
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Visual analysis of the graphs for P1 demonstrate the most marked changes in 
pain distress across the time frame of the study, reducing steadily from the maximum 
10/10 pain distress rating at baseline to 0/10 by week four and remaining at 0/10 
until the end. The graphs for pain intensity for P1 closely matches that for pain 
distress with only the ratings at week one differing (5/10 for pain intensity and 8/10 
for pain distress).  
Weekly pain intensity ratings for P3 appear stable across the nine timepoints 
with a peak corresponding with week five. P3’s pain distress scores show greater 
variation with an equivalent peak at week five but more pronounced troughs at week 
one and seven and an overall reduction in pain distress over time. 
Weekly pain scores for P4 show greater differences, with pain intensity ratings 
generally being higher than pain distress (range 6.5-9 for pain intensity and 4-8 for 
pain distress). What can also be seen from the graphs for P4 are that changes in pain 
ratings over the weeks were consistent in one direction as for P1, but both increased 
and decreased over time. The peak at week six coincides with P4 having a procedure 
under general anaesthetic which caused a spike in pain and difficulties practising the 
meditations. 
The pain graphs for P5 again show close resemblance to each other and 
following initial decreases up to week four, oscillate between ratings of 0/10 and 
4/10 until the end. The peaks at weeks five and seven represent ‘flare-ups’ of his 
Crohn’s disease. 
P10 dropped out of the study after week four due to increasing pain and 
finding the mindfulness unhelpful. Visual analysis of the pain rating graphs shows  
that whilst pain intensity remained generally high across this time period, pain 
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Timepoint 0= baseline 
Figure 6 Weekly ratings of pain intensity and distress 
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Figure 7 Weekly ratings of pain intensity and distress 
Timepoint 0= baseline 
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distress ratings increased. Anecdotal comments from P10 across the weeks described 
increasing problems with her feed (she was fed through a tube into her intestines) 
and uncertainty about the cause of the problems. This uncertainty may account for 
the increased distress recorded, while the pain intensity remained constant. 
Qualitative analysis 
All 15 participants were interviewed before beginning the mindfulness course 
and 13 were contactable to interview following the course. In addition eight 
participants provided brief written feedback after completing each week of the 
course. These qualitative data were analysed together in order to answer the second 
research questions: how useful and applicable do inpatients with gastrointestinal pain 
find MBSR methods? Brief descriptions of each participant’s pain characteristics are 
detailed in Table 4. 
Sections of the data where participants described their pain were not coded as 
they did not address the research question. Data were categorised under two broad 
headings (usefulness and applicability) and within these categories a general 
thematic analysis was undertaken (see Appendix 7 for an annotated example). Ten 
themes were found within three domains (see Table 5). Each theme is discussed with 
extracts from participants’ transcribed interviews and weekly written feedback. Data 
from all participants were analysed together but attention will be drawn to the 
differences between those that continued with the course (completer and incomplete 
groups n=6) and those that discontinued (non starter and drop out groups n=7). To 
enable clarity those that continued with the course will be designated C after their 
participant number and those that discontinued will be designated D. 
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Table 4 
Participant pain characteristics 
P Gender Ag
e 
Cause of gastrointestinal pain Pain 
years 
Completion 
status 
1C female 28 Gastroparesis as a complication of 
type 1 diabetes 
4 Completer 
3C 
 
female 52 Gastroparesis  13 Completer 
4C female 21 Pancreatitis, chronic pain syndrome 
and fibromyalgia 
17 Completer 
5C 
 
male 26 Crohn's disease 16 Completer 
7C female 44 Gastroparesis due to connective 
tissue disease, fibromyalgia and 
neuropathic pain 
20 Incomplete 
13C female 34 Gastrointestinal dysfunction due to 
spina bifida 
34 Incomplete 
6D male 46 Ulcerative colitis leading to most of 
the bowel being removed 
11 Drop out 
10D 
 
female 21 Addison’s disease leading to 
gastroparesis 
1 Drop out 
11D 
 
female 25 Crohn's disease 10 Drop out 
12D 
 
female 20 Unknown 1 Drop out 
14D 
 
male 29 Unknown 7 Drop out 
15D 
 
female 41 Tuberculosis in stomach 0.33 Drop out 
2D 
 
female 41 Crohn's disease 6 Non starter 
8D male 24 Spinal cord injury leading to 
intestinal dysfunction 
4 Non starter 
9D female 32 Blunt liver trauma subsequent to 
surgery for gallstones 
0.33 Non starter 
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Table 5  
Categories, domains, themes and sources 
Category Domain 
 
     Theme Number of 
sources 
Usefulness 
 
 
 
 
 
 
 
 
 
 
 
 
 
Applicability 
1) Hopes and 
expectations of the 
mindfulness course 
 
 
2) Outcomes/finding 
of the experience of 
doing the course 
 
 
 
 
 
 
3) Difficulties 
engaging with 
mindfulness/lack of 
fit with illness 
 
a) Reducing pain 
b) Increasing coping with pain 
c) Relaxation 
d) Low expectations 
 
e) Results from the course and 
what is different now 
f) When the techniques are 
useful 
g) Positive aspects of the 
course 
h) Negative aspects of the 
course 
 
i) Challenges of using 
mindfulness 
j) Barriers to starting or 
completing the course 
k) Suggestions of how it could 
be adapted 
4 
12 
8 
3 
 
7 
 
4 
 
7 
 
7 
 
 
5 
 
7 
 
8 
 
1) Hopes and expectations of the mindfulness course. Themes in this 
domain are focussed on what the expectations for the course were (reported both 
before starting the course and in retrospect at the end interview) and related 
primarily to interview questions on hopes for the course. Examples of all four themes 
within this domain were reported equally by participants that continued with the 
course and those that discontinued and therefore will be presented together. 
109 
a) Reducing pain. The aims of the mindfulness course were not to reduce 
pain intensity and this was explicitly discussed with participants before consent was 
gained. Despite this, several participants stated that they hoped the course would 
reduce their pain. Each participant usually qualified this hope with awareness that 
that might not be possible: 
P3C: I don’t know whether it can have any effect on the actual physical 
symptoms of my pain, that would be wonderful, I’m not sure on that 
P9D: the ultimate goal is to not be in pain, um, but I know that this can’t 
cure me 100% 
Although only a few participants explicitly mentioned this, I believe many 
more held this hope as several commented after dropping out of the course that it had 
not helped reduce their pain, implying that they had originally held this expectation. 
b) Increasing coping with pain. The vast majority of the data describing 
participants’ expectations and hopes for the mindfulness course concerned increasing 
coping with pain: 
P3C: to be able to cope with it, maybe cope with it better, I feel I cope with it 
quite well [sniff], because I’ve had it for so long 
P11D: just maybe a different way of, yet again, try and cope with pain 
because it’s something I am going to have for the rest of my life 
P14D: If it can help with enduring the pain and just, what’s the word I’m 
looking for, deal with it basically 
For many participants, increase coping with pain meant being able to cope 
with lower doses of medication, or to be able to delay needing the next dose: 
P2D: I’m on so many different medications and I thought if there’s some sort 
of way that I can do things slightly differently it might be better 
110 
P11D: that’s what I’d like to get out of it really, just try and get down off of 
such high medication with different coping techniques because I cope terribly 
with withdrawals 
P13C: so just maybe how to live with it and, because I don’t, I don’t like 
taking too many pain killers, um, because I always worry about my brain, 
like, when I’m older, and I don’t want my brain going to mush 
Some aspects of ‘coping with pain’ seemed to refer to not being so depressed 
by pain, or less preoccupied by it. Another interpretation is that ‘coping with pain’ 
reflects ideas of individuals’ responsibility for remaining in pain, that once medicine 
has done all it can for the patient, they just have to ‘learn to live with it’. 
P3C: I hate it when doctors say I’m a complex patient, I don’t want to be a 
complex patient I really don’t 
P4C: when you’re in the situation you don’t have a choice…you can’t fall to 
pieces 
P8D: I’ve had doctors tell me…“unfortunately you’ve just got to live with it” 
c) Relaxation. Participants also described relaxation as a key hope for what 
mindfulness could offer and linked increase stress/anxiety with heightened pain: 
P1C: I wanted to get a sense of, um, like relaxation because I was very 
anxious and, um, I just wanted to just like feel less anxious and less worried 
if I did get pain 
P12D: be more relaxed in myself, more comfortable because I get very tense 
and very worried and I think that just makes everything worse as well 
P9D: maybe because I’m so stressed that’s why I’m feeling the pain more 
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P14D: Because the pain is there, there’s nothing I can do about it, but 
thinking about it and stressing about it makes it worse, if there’s any way I 
can take my mind off it, I’m willing to embrace that 
d) Low expectations. Counter to the main emphasis with the theme of hopes 
and expectations of the mindfulness course, several participants reported honestly 
that they were fairly sceptical about the course and held low expectations, partially 
due to past history of trying techniques that they did not find helpful: 
P1C: I know it sounds a bit horrible in a way but I wasn’t really expecting it 
to do mind-blowing things 
P4C: this isn’t me being a pessimistic just a realist, I don’t, I don’t go in with 
any high, with any high expectations because a) I don’t really know what to 
expect, and b) I don’t want to expect anything and that shadow or prevent me 
from seeing or following something else that comes up 
P8D: I don’t really know really, to be honest, I’ve had, you know, when 
you’ve had something for so long and you’ve had so many people try and 
change it and alter it for you and nothing works… if you want my honest 
opinion I don’t think it will do anything but I’m willing to try it, I’m willing to 
try it 
2) Outcomes/finding of the experience of doing the course. Themes in this 
domain focussed on the experience of doing the mindfulness course, including 
outcomes from the course and when they found it useful. Themes on the positive and 
negative aspects of the course closely followed the questions about what they liked 
and did not like about the book, tracks and each section of the course. Most of the 
data that contributed to this domain originated from those participants who continued 
with the course. Although some who discontinued the course also contributed, this 
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domain is best illustrated by the participants who continued as they experienced 
more of the interventions and were better able to describe which elements they found 
useful. 
e) Results from the course and what is different now. This theme captured 
the descriptions participants gave of how they found the mindfulness course had had 
an effect; what the outcome of taking part was and how things had changed due to 
participating in the study. Of the four participants who completed the whole eight 
weeks of the course, three described it as an overall positive experience and one 
found it partially positive: 
P1C: it’s been a really good experience so far… it’s really helped me 
blossom in a way… I’m kind of sad that it’s come to an end 
P4C: overall a very positive one [experience] 
P5C: I think it was a bit helpful, yeah, yeah I think it was a bit helpful 
P3C: Sometimes it worked quite well and at other times it didn’t work at all 
well 
P7C: if I’d been able to get further, I think it would definitely have been a 
good experience 
Many participants reported finding it increased relaxation and helped to feel 
less anxious when in pain: 
P1C: I find it really relaxing, if I’m feeling sick I just remember the 
breathing exercises and it really does calm me down 
P3C: the relaxation part of it worked really well as I ended up falling asleep 
each time, which is a bonus when the pain has woken you up so managed to 
use it to get back to sleep 
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P5C: the things it was saying, like telling you to relax and stuff was just 
making your mind more relaxed 
f) When the techniques are useful. As well as discussing how they had 
found the mindfulness course had had an effect, the four ‘completers’ also detailed 
when they found the techniques to be useful: 
P1C: when I get pain, um, or when I’ve just vomited, that’s when I use it 
P3C: when I was having my line, when I was having my lines done recently I 
tried to use it then because I was in an awful lot of pain 
P3C: I’ve found I’ve called on it more in the acute setting than I have for the 
day to day stuff 
P4C: I find that I do the breathing one, um, that’s my main, my main weapon 
before I then ask for a dose of oxynorm [oxycodone] 
P5C: I was in too much pain so I was just waiting; I relaxed for a couple of 
hours to see if it would go away 
g) Positive aspects of the course. As well as describing the overall usefulness 
of the mindfulness course, participants also specified which aspects they found were 
particularly positive. Repeated mention was made of the first two weeks’ meditation; 
‘the body scan’ and ‘the breathing anchor’. Many participants reported finding these 
useful and positive as they were very straightforward, and could be used even when 
in a lot of pain, and week three’s ‘mindful movement’ was also singled out as 
particularly positive: 
P1C: I know I use it a lot, the first one, the body scan was the best one that I 
use… I find it really relaxing 
P3C: they were easier for me to do and I found them much more beneficial 
than the latter thing 
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P4C: I really enjoyed especially the first two, especially the first two, so the 
bodyscan and the um eh breathing anchor… They’re really really really 
simple ones that you can [do] even when you’re in absolute agony 
P4C: despite not being able to move freely at all, I have loved the mindful 
movement meditation. I have learned to focus on the positive feelings of the 
movements I can do and that in a way has started to override the negative 
feelings of pain and discomfort. This has become easier and easier to do and 
more automatic. It's meant that I don't fear movement anymore and feel I 
have more control.  
There was also mention that the book was clear and concise and gave 
straightforward instructions that could be easily followed: 
P1C: it’s got instructions and it tells you what to do it’s just sort of does it 
step by step with you  
P4C: it was another way of reinforcing what the- , what the meditations were 
in giving you a foundation to build on when you were listening to them, so for 
the for the more challenging ones it wasn’t something completely new that 
you were having to try  
P7C: I liked the case studies in the book.  
One participant found the case vignettes in the book particularly interesting: 
P7C: reading the case studies, the different examples, um that I found very 
helpful in the book 
Another positive aspect of the course that was repeatedly reported was the 
repetitive nature of the practice and how the knowledge and skills were built up 
gradually, week by week. 
115 
P1C: each one teaches you something different and I just found as you 
combine them and bring them like next one and then the next one, as you 
build them up, it makes a bigger picture 
P4C: that got better and easier with time as I got more practice 
P5C: repeating it so many times made it easier to understand and remember 
h) Negative aspects of the course. As well as describing positive aspects of 
the course participants also identified the less useful or less applicable elements. 
These included burden on time: 
P3C: I think when it’s new and you’re doing a new programme you’re very 
much looking at it the whole time and it just in certain ways it was like 
becoming a bit of a pain in the backside at times “oh god I haven’t done that 
this week, I best read that” 
Mention was also made several times of the sections of the book covering 
ideas of pacing were sometimes difficult, unhelpful or too time consuming. As the 
book was not written specifically for inpatient use, the pacing recommendations 
assumed you were in your own home and this made it difficult to adapt for some 
participants: 
P3C: I am finding it harder to do some of the exercises e.g. pacing as 
hospital is such an artificial environment 
P4C: The idea of keeping a 'pacing' diary made me feel stressed and 
burdened. I am good at pacing and can do it automatically. I don't want to 
pay it any special attention. Facing and thinking about it reminds me in a 
constant and unhelpful way that I am ill and cannot do all the things I would 
like to do. 
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One participant also found the reading level of the book fairly complex, and 
another that the book sections were overly long: 
P5C: it was a bit complicated, yeah, the words 
P7C: some of them [the chapters] were like, in some cases, really like 
substantially long, just too much to take in  
3) Difficulties engaging with mindfulness/lack of fit with illness. This 
domain focussed on the questions participants were asked about how the course may 
be adapted in light of their experience, and the factors that made continuation 
difficult. It captured some of the difficulties common to many people trying to learn 
a new strategy, but also the specific challenges for this patient group.  
i) Challenges of using mindfulness. The first theme, challenges of using 
mindfulness, described the difficulties participants experienced when doing the 
course, but that did not stop them from being able to engage with it and therefore are 
provided by those that continued with the course. These included consistently falling 
asleep during meditations, initially finding it difficult, distractions within a hospital 
environment, and burdens on time: 
P3C: I think in some ways it would be easier if it were all in hospital or it 
would be easier if it were all at home, it was difficult switching backwards 
and forwards between the two 
P4C: for most of the others, for at least a couple of weeks or so, I had to 
really focus on the person’s voice giving the instructions, and I was focussing 
so much on the instructions that actually doing the, eh, the kind of positive 
side of doing the meditation was getting lost in translation because I wasn’t 
focussing on doing that part, I was focussing on trying to listen and focus on 
what was being said 
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P5C: I found it ok, at first I didn’t find it ok so I had to keep going back but 
then I found it ok after 
P3C: because of how my illness is and what I have to fit in in a day to 
manage my illness I found [it was] adding in more and more things [to fit in] 
P13C: it was frustrating that I wasn’t able to do more, lots of things getting 
in the way…like the medications and the nurses in the day just getting in the 
way, and like kind of just outside life as well got in the way 
j) Barriers to starting or completing the course. Whilst the challenges made 
it difficult for participants to progress through the course, they did not stop them 
completely. There were however several barriers that prevented participants from 
starting the course or led them to drop out, not because they were not finding it 
helpful or thought that it might have a positive benefit, but because they were unable 
to find a way that it could fit into their life and their illness at the time. As they 
prevented them from completing the course, all the barriers were reported by 
participants who discontinued. The most significant barrier appeared to be due to 
illness, usually related to the condition that resulted in chronic pain: 
P2D: I was taken ill on the way home and then I was in and out of hospital 
for the next couple of months...which made it too difficult because I’d go in, 
be too sick and not be able to do it 
P9D: I wasn’t expecting to be so poorly, I wasn’t expecting my illness to be 
as consuming as it was 
P14D: I had spaces in between when I was too unwell and couldn't do it 
P15D: Everything, everything’s got in the way to be honest and it’s all down 
to my health, it’s all down to the diagnosis, the tablets, can’t tolerate the 
tablets 
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This was also the case for P12D, who though unable to complete an ending 
interview reported that the reason she had to dropout was due to being unwell back 
in hospital needing surgery. Closely related to the impact of illness were the barriers 
of frequently being readmitted to hospital: 
P2D: the most stressful thing was the being in and out of hospital because 
every time I was feeling like I was kind of getting back to being able to cope 
and do things then it felt like I was going backwards with that, kind of getting 
knocked down again with that, so I’d say that one, being in and out of 
hospital one was probably the worst, um, yeh, it was dreadful 
P6D: unfortunately when I came out of hospital last time there wasn’t a week 
went past that I wasn’t up here one or two days a week and that took it out of 
me so the next day I’d be in bed and I was just so tired all the time 
P9D: when I came out of hospital I had multiple rebound trips to my local 
hospital 
Another frequently cited barrier to being able to use the mindfulness course 
was lack of time, both generally and because of demands on time from illness 
regimes: 
P9D: I couldn’t give anybody any length of time; I couldn’t even give myself 
time 
P10D: [I’d] end up spending the whole day, essentially, trying to meditate 
k) Suggestions of how it could be adapted. Of the participants who 
continued with the mindfulness course, many had suggestions of how the course 
could be improved or adapted for patients with gastrointestinal pain. One suggestion 
was for the course to be delivered all in one location as it was difficult to transition 
between hospital and home: 
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P3C: in an ideal world it would be eight weeks in hospital 
P13C: when you’re in hospital, you actually, you get bored so you’d be more 
focussed to do it as well, whereas when you’re back at home, as well as sort 
of dealing with your own pain and health issues, life gets in the way 
Another suggestion was to simplify the material in the book or to change the 
format of the book to make it easier to follow when unwell: 
P4C: I would try and make it even less complex, because, I mean it’s really 
good having other people’s experiences in there but on my, um, on my days 
when I wasn’t feeling too good, I found, I found that difficult, sometimes 
difficult to get past, and I’d get lost 
P5C: language I think more simpler 
P7C: I think it would be easier to listen to something rather than try to read 
it yourself 
In terms of adaptations of the course specifically to meet the needs of patients 
with gastrointestinal pain, one participant in particular emphasised the need to tailor 
the course individually to each patient, rather than as a block course: 
P3C: with these, sort of like, the the little package that, um, we’re trying to 
do with this mindfulness thing is that I think for the us strange patients 
who’ve got gut problems I don’t think it’s unfortunately going to be a thing 
that we can just pick off the shelf …I say tailoring it to somebody to how they 
actually need it, that’s how I see it progressing…if I left it just as it was, I 
wouldn’t get an awful lot from it 
Another participant recommended including case study vignettes from 
patients with gastrointestinal pain in the book as well: 
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P7C: it would be quite good maybe to have someone, maybe with gastro pain 
or people that have long term chronic illnesses 
 
Discussion 
The effectiveness and acceptability of a guided self-help mindfulness course 
for chronic gastrointestinal pain was evaluated with 15 inpatient participants. A 
multiple single case design was used to assess change in pain ratings over time, in 
addition to baseline and endpoint quantitative outcome measures. Qualitative 
interviews were used to evaluate the course’s usefulness and acceptability with this 
population. First the findings will be summarised and then discussed within the 
context of the wider literature. Following this the strengths and limitations of the 
study and clinical and scientific implications will be discussed. 
Summary of findings 
1. Can an individual mindfulness intervention for inpatients with 
gastrointestinal pain reduce pain-related distress, improve quality of life, and 
increase confidence in pain self-management? 
Pain distress ratings reduced over the period of the intervention by a 
clinically significant amount from baseline to endpoint for all four participants who 
completed the mindfulness course. Pain distress and pain intensity ratings were 
closely associated for some participants, but for others pain distress ratings decreased 
whilst pain intensity remained relatively constant. Participants who had completed it 
reported that the mindfulness course was “a really good experience” (P1C) and 
straightforward enough to be used when acutely unwell “you could do it even when 
you were really poorly; you didn’t have to be at the top of your game in order to 
interact with it and do it” (P4C).  
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With regard to improved quality of life, measures of psychological distress 
decreased for the majority of ‘completers’. Participants reported that some negative 
emotions became less frequent “I’m not so anxious, I’m not so, um, worried, um, as 
what I’d used to be” (P1C) whilst others reported that negative emotions still 
occurred but were less distressing “they’re not so sharp and painful” (P4C)  
Confidence in doing things despite pain increased following the intervention 
with three ‘completers’ reaching reliable and clinically significant improvement. No 
changes were observed in pain acceptance. Mindfulness skills increased across the 
course with clinically significant improvements for three out of four ‘completers’. 
2. How useful and applicable do inpatients with gastrointestinal pain find 
MBSR methods? 
Prior to beginning the mindfulness course, most participants hoped that it 
would help them to cope with pain whilst a smaller number also hoped it would 
reduce pain intensity (contrary to descriptions of the study). Several participants had 
low expectations of the course due to previous disappointing experiences. Those who 
continued reported that, overall, doing the course was a positive experience and 
several of those that dropped out or were unable to start said that they would like to 
be able to engage with mindfulness in the future. Overwhelmingly the earlier 
sections of the course (body scan and breathing anchor meditations) were described 
as being useful, easy to follow and most used by those who completed all sections of 
the course. Participants differed in being able to use the mindfulness techniques 
during intense pain, or finding it too difficult. Overall the book and audio tracks were 
found useful and applicable but for a minority of participants the book was too long 
or complex. Some participants also commented that finding time to practise 
mindfulness was a burden with the complex regimes required of their illnesses. This 
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was cited both as a challenge by those who continued and as a barrier by those who 
discontinued. 
Three fifths of the sample discontinued the course. Only two of these nine 
participants reported dropping out due to finding the mindfulness course unhelpful. 
The remainder reported barriers to completion related to their illness and healthcare 
and to external stresses. Participants who continued with the course made 
suggestions for how it could be adapted to improve the fit for inpatient chronic 
gastrointestinal pain patients including: introducing the course during an extended 
inpatient admission, reducing the complexity of the book and producing an audio 
version; and tailoring the course for each patient, with clinician contact. 
In summary, the data from the four ‘completers suggests that a guided self-
help mindfulness course shows potential benefits for inpatients with gastro intestinal 
pain although with such a small number completed, these results must be taken with 
caution. The challenges and barriers faced by this population of chronic and complex 
gastrointestinal pain patients are significant and so adaptations to standard MBSR 
delivery are needed. 
Wider context 
The current study investigated only a small sample of heterogeneous 
gastrointestinal pain patients and results cannot be generalised to the wider chronic 
pain/chronic illness populations. However the findings were in line with previous 
reports of positive outcomes following mindfulness interventions including the 
original accounts of MBSR with outpatients with pain and illness (Kabat-Zinn et al., 
1985). Although reductions in pain intensity were not an aim of the present study, 
clinically significant improvements occurred for two of the four ‘completers’, as has 
been reported in recent meta analyses (Baer, 2003; Grossman et al., 2004; Reiner et 
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al., 2013). Another meta-analysis (Chiesa & Serretti, 2011) reported strong benefits 
of mindfulness on depressive symptoms (as found in this study) and on coping with 
pain (demonstrated in this study through measures of increased confidence in doing 
activities despite the pain and qualitative reports of increased abilities to use 
relaxation to cope with pain). Patients with gastrointestinal pain frequently have 
multiple additional medical and psychological difficulties and the initial positive 
results in this study may have resulted from improvement in these factors. 
Mindfulness interventions have shown promising effects on improving depressive 
symptoms and quality of life for patients with fibromyalgia (Grossman, Tiefenthaler-
Gilmer, Raysz, & Kesper, 2007; Sephton et al., 2007), improving symptoms and 
abdominal pain in IBS (Gaylord et al., 2011) and ameliorating depression, anxiety 
and fatigue in patients with multiple sclerosis (Grossman et al., 2010). 
Measures of acceptance of chronic pain did not increase reliably for any of 
the four ‘completers’. This may be due to participants’ initial baseline scores being 
considerably lower than the mean of the clinical population with which they were 
compared. Although it was the most similar published data set in terms of sample 
characteristics, the majority of that population reported back pain, and were not 
currently under treatment. Participants in this study were in active inpatient treatment 
for gastrointestinal problems, including infections, procedures and pain management. 
Another possible account is that changes to pain acceptance may not be sensitive 
over the short term, and longer term practice with mindfulness may demonstrate later 
increases in acceptance. 
Qualitative findings. Participants’ responses during the semi-structured 
interviews revealed useful practical information about their expectations of 
mindfulness, the outcomes and the challenges they faced.  
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When participants spoke of wanting to increase their abilities to ‘cope with 
the pain’, one interpretation was that they had internalised the expectations of 
‘western medicine’ that it was their responsibility to ‘cope with the pain’. Within the 
traditional working model of most healthcare interactions there is an assumption that 
illness and pain are acute and temporary. Following from ideas proposed by 
Foucault, since the birth of modern medicine the disease entity has been objectified 
and separated from the person (Foucault, 1963) and has a mechanical manifestation 
and solution. This model does not fit well with chronic pain and illness as often a 
‘fix’ or ‘cure’ is not possible. From the clinicians’ perspective, concepts of 
responsibility for health and illness are shifted away from the medical practitioner 
and placed back on the patient (Eccleston, Williams, & Stainton Rogers, 1997).  
One of the significant challenges/barriers participants reported when trying to 
engage with the mindfulness course was difficulties finding time. During weekly 
feedback, participants repeatedly reported being unable to complete that week’s 
mindfulness practice and to progress. They frequently reported frustration about the 
limits imposed on them by pain and illness and the needs and responsibilities of their 
lives ‘outside’. For many participants, being ill and in pain was a fulltime ‘career’, 
both literally in terms of hours spent in hospital, attending outpatient appointments, 
taking medication, enteral feeds and visits from district nurses, and symbolically in 
terms of the amount of emotional time and energy taken by living with pain and 
illness. The majority of participants spoke of how this left little time for their ‘real’ 
life, families, work, friends, goals, desires and interests. These findings fit with other 
qualitative accounts from patients living with chronic pain and illness including 
individuals with IBS who described constantly living on the borderline between 
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wellbeing and illness (Delmar et al., 2005) and time constraints being one of the 
main barriers to self-management of pain (Bair et al., 2009). 
Plausible mechanisms. As a feasibility study, the results reported here 
cannot demonstrate causal relationships between practice of mindfulness and 
reduced distress of gastrointestinal pain. However the promising findings can be 
discussed against several proposed mechanisms which attempt to account for similar 
findings in research of larger, controlled studies. 
Following completion of the course, increases in mindfulness as measured by 
the FFMQ were observed; unfortunately, the sample size was too small to test for 
associations with the other improvements. Studies of MBSR for patients with IBS 
demonstrated significant correlations between increases in mindfulness scores and 
decreases in gastro-specific anxiety after eight weeks of MBSR, maintained at six 
month follow up (Kearney, McDermott, Martinez, & Simpson, 2011). Further 
research could investigate whether decreases in anxiety (and specifically gastro-
specific anxiety) is a mediating factor between increases in mindfulness skills and 
reductions in gastrointestinal pain.  
The majority of participants who continued with the course reported feeling 
more relaxed as an outcome from practising the mindfulness. Anxiety and fear 
amplify pain (Keefe, Rumble, Scipio, Giordano, & Perri, 2004) and greater 
activation of limbic (emotion processing) areas of the brain is found in chronic 
compared to acute pain (Apkarian, Hashmi, & Baliki, 2011). Therefore, if relaxation 
can reduce anxiety and fear, pain may also decrease. One participant particularly 
illustrated the powerful impact of anxiety on the distress of being in pain “if I’m 
feeling sick I just remember the breathing exercises and it really does calm me 
down” (P1C). She found the straightforward meditations in the mindfulness course 
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helped to break the vicious cycle of pain and anxiety. This finding was also 
demonstrated in a qualitative study of older adults’ experiences of using mindfulness 
for back pain (Morone, Lynch, Greco, Tindle, & Weiner, 2008).  
Several imaging studies have investigated the neural correlates between 
mindfulness practice and reduced distress indicating that changes occur at a neural 
level. Changes in anticipatory processing in the dorsolateral prefrontal cortex and 
somatosensory cortices indicated improved regulation of the emotional responses to 
pain which related to improved mental health following mindfulness training for 
patients with chronic pain (C. A. Brown & Jones, 2013) rather than being related to 
reduced pain experience. Anticipatory anxiety about pain increases the perceived 
intensity of identical stimuli (Ploghaus et al., 2001). Meditation has been shown to 
reduce the anticipation and negative appraisal of pain and this has been associated 
with differential activation of the midcingulate cortex and medial prefrontal cortex 
(C. A. Brown & Jones, 2010). 
Distraction is sometimes reported to be an effective coping strategy for 
managing pain (Buhle, Stevens, Friedman, & Wager, 2012). Mindfulness training 
instructs individuals to focus on sensations rather than distract from them and is 
reported to be effective. It is argued that it is not whether we attend to pain 
sensations that impacts on brain processing so much as how we attend to them 
(Buhle & Wager, 2010) with the emphasis in mindfulness practices to resist 
evaluating the sensations, and merely notice that they are there. 
Strengths and limitations 
This study represented the first attempt to deliver guided self-help 
mindfulness to inpatients with painful gastrointestinal illness. Use of a small sample 
and multiple single case design and qualitative methods allowed in depth analysis of 
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each participant’s experience. It also enabled data to be gathered about the 
challenges and barriers facing inpatients with gastrointestinal pain attempting to 
develop mindfulness skills. This is a chronically ill population with pain that faces 
unique challenges besides chronic pain, such as enteral feeding and associated 
frequent infections. The severity and complexity of the condition s many participants 
were experience meant that this population differed from the standard chronic pain 
samples recruited to most studies of psychological approaches to pain management 
which require attendance at outpatient appointments as a minimum. Most of the 
current population who experience repeated admissions to hospital would not be able 
to participate in research in outpatient settings. 
The small sample used does not enable generalisation, nor modelling of the 
impact of external variables on the trajectories of pain distress, quality of life and 
confidence managing pain. Recruitment took place while participants were inpatients 
on specialist gastrointestinal wards, and throughout the period of study many had 
changes to medication, medical procedures, recurrent infections, and social changes 
that may have impacted on the results. 
Recruitment of participants was difficult to achieve on the busy hospital 
wards. The recruitment procedure required nursing or medical staff to identify 
potential participants. Several potential participants commented that they had been in 
hospital for many weeks and would have found it useful to begin the mindfulness 
course sooner. Although recruitment discussions were held with nursing staff 
weekly, most ‘referrals’ were biased towards patients who were requesting high 
levels of opioid medication and were nearing discharge, and were therefore a 
concern for staff, while patients whose pain was well controlled by medication were 
less likely to be ‘referred’. 
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Attrition accounted for a large proportion of the sample. This was anticipated 
as participants were unwell. Loss of participants reduced the total number of 
‘completers’ below the eight originally intended for analysis. As already discussed, 
most research into chronic pain does not recruit from populations with multiple and 
complex pain presentations with repeated hospital stays. The high attrition rates in 
this study could be attributed to the severe and complex nature of the health 
problems participants were facing. Although it resulted in only a small number 
completing and provided end data for analysis, seven of the nine participants were 
interviewed and provided valuable data on feasibility. 
Implications 
Clinical. This study relates directly to clinical practice and several 
implications have emerged. This study emerged out of a comprehensive review of 
pain management methods at a major university teaching hospital and a working 
group is already in place to be able to take forward the findings from this study. A 
guided self-help mindfulness course was feasible and found to be useful and 
applicable to participants who completed the course, but requires further adaptations. 
This provides preliminary evidence that mindfulness should be developed further as 
an intervention for some inpatients with gastrointestinal pain, in addition to their 
medical care.  
There are current debates about the degree to which extended practice with 
mindfulness is necessary for positive outcomes (Carmody & Baer, 2008, 2009; 
Vettese, Toneatto, Stea, Nguyen, & Wang, 2009). Given the challenges on time 
reported by participants and the near universal reports that the initial two meditations 
were the most useful and frequently used, it could be argued that development of a 
briefer version of the materials currently used would be of benefit.  
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Introducing brief mindfulness materials and guided meditations to inpatients 
may provide a time-efficient method of pain management for individuals. Many 
participants described difficulties fitting in practices at home alongside all the 
distractions of being unwell. This population often experience extended inpatient 
admissions and there are few opportunities for them to fill their time and manage 
their conditions. An audio ‘podcast’ introducing mindfulness and the bodyscan and 
breathing anchor meditations could be made accessible to patients via their bedside 
entertainment systems. Nursing/medical staff or peer support volunteers could raise 
awareness of these resources and be available to discuss their use with patients to 
help manage anxiety, prepare for procedures and educate patients about non-medical 
approaches to pain management that are available to them in the future if needed. 
Further evaluation is necessary to investigate the efficacy of this approach, and to 
establish cost-effectiveness. It would also need to be thought about carefully for 
which inpatients would benefit from being introduced to mindfulness and not merely 
presented as a panacea to all. 
Use of relaxation tapes/resources is widespread in pain management settings 
and yet several participants who demonstrated improvements following the 
mindfulness course reported that previous attempts with other relaxation resources 
were unsuccessful. Specific elements of the mindfulness course that were described 
as helpful compared to standard relaxation was the addition of the book providing 
psychoeducational information about pain and providing an extended rationale for 
using mindfulness to aid living with pain. This step appeared to be important in 
building motivation to persist with the practices, something which is likely to be 
reduced if a patient is offered a relaxation CD without additional guidance. There is 
extensive support for the efficacy and effectiveness of guided self-help or ‘minimal-
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contact’ interventions with chronic pain, chronic illness and IBS (Ahl, Mikocka-
Walus, Gordon, & Andrews, 2013; Beatty & Lambert, 2013; Bender, 
Radhakrishnan, Diorio, Englesakis, & Jadad, 2011; Matcham et al., 2014) with 
outcomes comparative to therapist delivered interventions (Pajak, Lackner, & 
Kamboj, 2013). In addition the meditations were adapted for individuals in pain, one 
participant reported that she had always struggled with taking deep breaths when 
previously instructed to relax, but found the mindfulness instruction of observing 
breaths much easier to use and much more effective. 
Another clinical implication emerging from this study is the high rate of 
attrition of participants being unable to begin/complete the course. In clinical use this 
could be reduced by developing a briefer version as discussed. It may also be the 
case that this will be most effective when patients are able to practise and develop 
the skills whilst on the ward for an extended period, and may be less useful if 
presented shortly before discharge. 
Scientific. This study demonstrated the potential usefulness of guided self-
help with inpatients with gastrointestinal pain but further research is needed due to 
the high rate of drop out in this study, and the positive findings relating to only four 
‘completers’. The next step would be to use this data to inform a larger study to 
confirm the present findings. It would be important for future expansions of this 
research to include a follow-up period of not less than six months to capture the 
effects of ongoing mindfulness practice. Previous studies of MBSR for IBS found 
that non-significant improvements in quality of life and gastro-specific anxiety 
reported at the end of the course became significantly improved after six months 
(Kearney et al., 2011). Further investigation of the importance of the frequency and 
duration of mindfulness practice would also be fruitful. As burden on time was 
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reported to be one of the particular challenges of this group in engaging with the 
course, reducing practice requirements could increase the acceptability of the 
programme. 
The qualitative components of the current feasibility study were strongly 
influenced by the needs of the quantitative analysis and were restricted to evaluating 
the course. Following a larger trial of guided self-help mindfulness for patients with 
gastrointestinal pain, an exploratory and deductive qualitative investigation of 
individuals’ experiences of using mindfulness, including over the longer term, would 
provide valuable information on how individuals assimilate ongoing mindfulness 
practice into their pain management regimes and what they ascribe the long term 
impact of mindfulness to be. 
Conclusions 
A guided self-help mindfulness course for inpatients with gastrointestinal 
pain and illness shows potential to reduce pain-related distress, improve quality of 
life and increase confidence in pain self-management following completion. Despite 
significant challenges and barriers to participation for this patient group, those who 
were able to complete the course reported an overall positive experience, increases in 
relaxation and decreases in pain-related anxiety. Pain distress ratings reduced for all 
participants who completed the course and for some pain intensity also reduced. 
Clinical implications include developing a briefer version of the course to provide on 
patient bedside entertainment systems for general use by a wider group of patients. 
This feasibility study provides proof of concept for further RCTs in this area to 
enable greater generalisations and exploration of causal mechanisms. 
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Critical appraisal 
Previous experiences 
Prior to embarking on clinical training, my previous experience and personal 
interests oriented me towards health psychology. My choice to study psychology as 
an undergraduate was influenced by the appeal that as an area of enquiry, 
psychology employed both reductionist, evidence based scientific methods similar to 
medical sciences, as well as interpretative higher level understandings of the human 
condition and contextual influences. Within health psychology, I found the interface 
between medical sciences of disease process, and social sciences of what it is to be 
human, a fascinating area of study. Clinical psychologists, as scientists schooled in 
both disciplines, are well placed to be able to bring together methods from both 
perspectives. It was within this context that I sought to conduct my major research 
project within health psychology and which influenced my choice of mixed 
methodology. 
Choice of approach (mixed methods) 
Choosing a mixed methods approach was primarily led by the research 
questions but also fit with my epistemological stance which I would describe as 
critical realist. Similar to my view of the strengths of psychology in drawing on both 
quantitative and qualitative traditions, I believe that research in psychology should 
produce data that both brings us closer to the reality of the human brain and 
behaviour, but that also recognises that we are restricted in our understanding of that 
reality as it is perceived and interpreted through our own brains and behaviour. 
Challenges on wards 
When choosing this topic of research I was aware from the outset that 
conducting research in a busy inpatient hospital environment would mean that I 
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would be working with the whole staff team in an indirect way, even though the 
focus of my research questions was with patients. With knowledge of both my 
personal experience working as a healthcare assistant on an inpatient ward, and of 
psychological theories of systems and group dynamics, I was aware that I would 
need to present myself as non-threatening and non-blaming towards the staff teams, 
especially as I was reliant on their support to identify potential participants. I drew 
on systemic models of increasing levels of context influencing individuals’ 
experience. For example, each nurse on the ward would have her/his own personal 
beliefs, attitudes and experiences towards pain management. This would also be 
influenced by the beliefs, attitudes and experiences of their immediate contexts. This 
in turn would be influenced by the context of the whole hospital (which at this time 
had embarked on improving pain management for its inpatients including rolling out 
educational programmes for nurses), which in turn would be influenced by the wider 
societal context of increasing demands and expectations on nurses, despite reduced 
resources.  
My experience on the ward mainly consisted of interactions with the nursing 
staff rather than other health professionals as they were the ‘gatekeepers’ to potential 
participants and kindly supported my research. I quickly learnt which staff were 
interested and intrigued by the research, saw its potential for patient and staff benefit, 
and were willing to identify possible participants. There were also staff who 
appeared less interested or dismissive of the research or viewed my request for 
participants as ‘one more thing’ they were expected to do on top of an already large 
list of demands on their time. It could be easy at times to slip into a position of 
judging these staff members as wanting to avoid work or enjoying the power they 
had over me (when in most of their work the power was viewed as being held by the 
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doctors). However, when viewed in the context of the many layers of pressures and 
expectations they were under, their reactions were much more understandable. 
Recruitment challenges 
This research project took place in the context of a hospital trust who were 
committed to improving the experiences of patients with pain whilst in hospital and 
had set up a working group to assess the situation and implement solutions. The 
gastrointestinal failure wards were identified as an area where a lot of patients had 
significant levels of pain, often difficult to manage pharmacologically. When invited 
to propose a research project within these wards we expected to have few difficulties 
recruiting patients. Staff reported that across the 90 beds on the two wards, many 
patients had extended hospital stays and there would be little issue in recruiting the 
desired eight participants and implement the eight week intervention.  
Following eight months of recruitment, 15 participants had consented to take 
part but by the end of data collection only four had completed the intervention and 
only one of these had been an inpatient for the whole programme. This resulted in a 
change of focus of parts of the research project, particularly the qualitative 
component. The original intention had been to gather data on participants 
experiences of the mindfulness intervention following completion and analyse for 
common themes. As only four participants could provide this data, the focus of the 
qualitative analysis was widened to include the experiences of participants who had 
been unable to complete the programme, and to analyse the common themes that 
arose in relation to this.  
As is often the case when conducting research, it can be disappointing when 
your data collection does not match up to your hopes. In this case however, the 
necessary change provided rich and interesting data about the barriers and challenges 
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participants faced when trying to complete the course. Before conducting the 
research I had underestimated difficulties this population faced. I had known 
intellectually but had not appreciated the full impact this would have. Through 
conducting the research I was able to gather a much richer understanding. 
Dual roles and tension in research 
The process of completing the doctoral training in clinical psychology is one 
of inhabiting dual roles; the clinician and the researcher. Whilst being an avid 
consumer of research in clinical psychology, prior to training I envisaged myself 
primarily as a clinician rather than a researcher. This was mainly due to an 
assumption that research is something that is done ‘at a distance’ from those it 
concerns; that research is done ‘to’ clients whereas therapy is done ‘with’ clients. 
Using a single-case design for my research allowed me to challenge my assumptions 
and experience; conducting research much closer to current clinical health 
psychology practice.  
Although a single case design and qualitative analysis allowed me to inhabit 
the role of a researcher quite similar to my working preferences as a clinician, I still 
found there was an inherent tension between the two roles at times. In certain 
circumstances the skills of an objective researcher were more important. This was 
evident when conducting the semi-structured interviews and reminding myself to 
take a curious, not-knowing stance and not feel the need to ‘jump in’ and support the 
participant. Many participants’ descriptions of their pain and the impact it had on 
their lives was highly emotive and the skills of a clinician were important to be able 
to hear the emotive content, manage the emotions it arose in myself, and respond to 
the emotions that arose for the participant in a respectful and validating way. I found 
that I had to be constantly aware of balancing the need to be empathic towards the 
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participants and respond in an ethical way to their distress, as well as trying not to 
lead the participant to describe their experiences in the ways I was making sense of 
them. To manage this tension I maintained a reflective component to my research 
diary and thought about how I managed similar situations in my clinical work.  
I found it helpful to think of the research interviews as similar to clinical 
assessment sessions. In an assessment I would both aim to facilitate a good 
therapeutic alliance, by sensitively responding to clients’ distress and experiences, 
whilst also aiming to gather data. I would try to hold several different hypotheses in 
mind at once, asking clarifying questions and checking with clients on their 
understanding not to impose my own assumptions. I also sought peer supervision 
with other trainees who experienced similar tensions between their two roles and 
shared ideas of how best to manage. 
Impact of the researcher on the research 
When conducting the qualitative aspects of this research project, I was aware 
that it is not possible for a researcher to be entirely objective and my interpretations 
of the data will necessarily be influenced by my own contexts, thoughts and 
assumptions. However, it was only on reflecting on the research as a whole that I 
considered the impact that my own contexts, thoughts and assumptions may have 
had on the raw data generated even before it was analysed and interpreted. When I 
listened to audio recordings of the interviews and re-read the transcripts I noticed the 
highly personal and emotive accounts many participants gave of their experience of 
living with chronic pain and experience of a mindfulness intervention. At the time I 
had not thought this unusual as my previous interactions with patients in health 
psychology settings as a clinician had been very similar. However, on reflection, I 
wondered whether patients had been able to give such personal accounts because I 
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was a psychologist, and whether they would have given different accounts had the 
research been conducted by a doctor or nurse. 
Impact of the research on the researcher 
My assumptions prior to clinical training were that clinical and research roles 
were very distinct and that by focussing time on conducting research, one had to 
sacrifice time spent in clinical roles. What this research project has taught me is that 
there are several ways in which the role of researcher can be complementary to the 
role of a clinician, whilst still producing valuable data. This knowledge was mostly 
gained from my experience of using a single case design. By having a small number 
of participants, I was able to personally deliver the intervention in every case and 
chart their progress throughout. At the analysis stage I was also able to stay with the 
richness and idiosyncratic nature of each participant’s data, whereas this would not 
have been possible with larger scale group level analyses. I found that single case 
design research is compatible with ongoing clinical work and hope to continue 
conducting this type of research once qualified; something I had never previously 
anticipated. 
Conclusions 
Before completing this research project I already knew that I wanted to focus 
on the area of clinical health psychology once qualified. I had not expected to also 
want to continue conducting research in this area. The challenge of high levels of 
attrition provided an alternative focus for parts of the qualitative analysis which I 
believe adds to the richness and usefulness of the data. I look forward to facing more 
of these challenges in the future. 
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Appendix 2: Weekly feedback questionnaire 
Weekly Feedback 
How intense was the pain on average over the last week? 
 
0 1 2 3 4 5 6 7 8 9 10 
How distressing was the pain on average over the last week? 
 
0 1 2 3 4 5 6 7 8 9 10 
 
This week, how has the pain made you feel emotionally?  
……………………………………………..……………………………………………..…………………………
…………………..……………………………………………..……………………………………………..……
………………………………………..……………………………………………..……………………………… 
……………………………………………..……………………………………………..…………………………
…………………..……………………………………………..……………………………………………..……
………………………………………..……………………………………………..……………………………… 
………………………………………..…………………………………………………………………………… 
How many times have you used mindfulness this week?  
0 1 2 3 4 5 6 7 8 9 10+ 
For how long on average each time?  ……..minutes 
What went well? 
………………………………………..…………………………………………………………………………… 
……………………………………………..……………………………………………..…………………………
…………………..……………………………………………..……………………………………………..……
………………………………………..……………………………………………..………………………………
……………………………………………………………………..………………………………………..………
What didn’t go well? 
………………………………………..…………………………………………………………………………… 
……………………………………………..……………………………………………..…………………………
…………………..……………………………………………..……………………………………………..……
………………………………………..……………………………………………..………………………………
……………………………………………………………………..………………………………………..……… 
  
No pain Extreme pain 
Not distressing at all Extremely distressing 
153 
Appendix 3: Pre-intervention interview schedule 
Interview Schedule Start 
 
 
How would you describe your pain? 
 
 
How long have you been in pain? 
 
 
Is there an explanation or a diagnosis the doctors have suggested for the 
cause of the pain? 
 
 
How do you relate to your pain? 
 
 
Has your relationship to the pain changed over time? 
 
 
Do you ever visualise your pain? If you did what would it look like? 
(size, colour, shape etc.) 
 
 
What would be your hopes for the mindfulness course? 
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Appendix 4: Post-intervention interview schedule 
Interview Schedule End 
 
 
What was your experience of using the mindfulness exercises? 
 
 
What did you like/what was helpful about the mindfulness exercises? 
 
 
Was there anything you didn’t like/wasn’t helpful about the mindfulness 
exercises? 
 
 
What did you like/what was helpful about the reading? 
 
 
Was there anything you didn’t like/wasn’t helpful about the reading? 
 
 
How are you doing now? What changes, if any, have you noticed in yourself 
since starting the mindfulness? 
 
 
In general, what do you attribute these changes to? What do you think might 
have brought them about? (both from mindfulness or outside) 
 
 
Was there anything missing from the mindfulness course? 
 
 
Were there any ways in which you adapted/changed the course? 
 
 
What has it been like for you to be involved in this research? 
 
 
Do you have any suggestions for us, regarding the research or the 
mindfulness itself? 
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Appendix 5: Drop-out/non-starter interview schedule 
Interview Schedule non-starter/drop-out 
 
 
What were the main reasons for you wanting to start doing the mindfulness 
course? 
 
 
What were the main reasons for you not to be able to start/finish? 
 
 
Which things got in the way? 
 
 
How could the course be changed/adapted that would have made it 
easier/more suitable? 
 
 
Would there be a better time/what would need to be different in the future 
for it to be possible for you to do the mindfulness course? 
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Appendix 6: t-tests of demographic variables comparing participants who did 
not start/dropped out and participants that continued with the course 
Group Statistics 
                                                 CompletionStatus N Mean Std. Deviation Std. Error Mean 
BaselineHADScomposite 
Completer/incomplete 6 16.50 6.921 2.825 
Non-starter/dropout 9 22.56 10.584 3.528 
BaselinePSEQ 
Completer/incomplete 6 19.83 11.583 4.729 
Non-starter/dropout 9 17.44 14.046 4.682 
BaselineFFMQtotal 
Completer/incomplete 6 120.00 17.754 7.248 
Non-starter/dropout 9 117.56 26.857 8.952 
BaselineCPAQtotal 
Completer/incomplete 6 47.33 20.373 8.317 
Non-starter/dropout 9 38.22 22.438 7.479 
Baselinepainintensity 
Completer/incomplete 6 6.50 3.450 1.408 
Non-starter/dropout 9 7.50 1.118 .373 
Baselinepaindistress 
Completer/incomplete 6 5.83 3.251 1.327 
Non-starter/dropout 9 6.83 2.424 .808 
 
  
Independent Samples Test 
 
 Levene's Test 
for Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df Sig. (2-
tailed) 
BaselineHADScompos
ite 
Equal variances assumed .820 .382 -1.229 13 .241 
Equal variances not 
assumed 
  -1.340 12.998 .203 
BaselinePSEQ 
Equal variances assumed .570 .464 .345 13 .736 
Equal variances not 
assumed 
  .359 12.250 .726 
BaselineFFMQtotal 
Equal variances assumed .740 .405 .195 13 .848 
Equal variances not 
assumed 
  .212 12.993 .835 
BaselineCPAQtotal 
Equal variances assumed .042 .841 .798 13 .439 
Equal variances not 
assumed 
  .815 11.611 .432 
Baselinepainintensity 
Equal variances assumed 
3.28
5 
.093 -.821 13 .427 
Equal variances not 
assumed 
  -.686 5.707 .519 
Baselinepaindistress 
Equal variances assumed .009 .927 -.685 13 .506 
Equal variances not 
assumed 
  -.644 8.651 .536 
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Appendix 7: 
 
P4 End interview 
What was your experience of using the mindfulness exercise over the  
last nine weeks? 
Umm, overall a very positive one. I came in being quite sceptical because 
 my mum is very very very into mindfulness and she’d gone she’d gone  
from being, beforehand if I’d had any negative emotions then she’d be  
talking me through whereas when she started mindfulness she started  
“oh well just let it go it’s not important” which I felt was dismissive, but  
now I know what she means because you learn what, well, you don’t let  
go of them, um, but you, relearn and resort them if that makes sense?  
So the really really negative ones, um, you, they you learn to dull, dull  
their edge so they’re not so sharp and painful, they’re still obviously still  
painful but they’re not sharp and don’t stay there for long periods of  
time, yeh 
So overall very good one? So what did you like about the mindfulness  
exercises? 
Um, I liked that they were simple, easy to remember so you didn’t have  
to keep the referring to the book. I found one confusing that may have  
been because that week I’d had a general anaesthetic [laughs] 
Which week was that? Do you remember which? 
That was umm, I can’t remember which week but I remember it was the  
open heart one and still now, I think that was week 5, it was either week  
five or week six, round about that area, um and I just found it and still do  
find it confusing, I don’t understand it, um but all the others I really  
enjoyed especially the first two, especially the first two, so the bodyscan  
and the um eh breathing anchor 
Yeh, and what is it about those two that you preferred to the others? 
They’re really really really simple ones that you can even when you’re in  
absolute agony and when you are in that kind of place, literally it sounds  
strange but other, but when I’ve talked about this with other people  
who are ill, are in the same kind of experience they find that the world  
just goes, it kind of loses all its colour, it’s as if your non essential organs  
and things, kind of not shut down, but you don’t notice them anymore,  
so the world loses its colour and becomes darker and dimmer, I mean  
kind of visually as well as emotionally, um so when you’re in that kind of  
pain where there isn’t, you literally don’t, it’s so overwhelming that it  
seeped into absolutely everything, it can be or is, that can be but is, very  
difficult to be able to draw out a meditation or anything at all that isn’t  
related to how much pain you’re in. So those two are so simple, and are  
so basic, you can um, you can use them, and you can draw on them even  
when you’re right down in the darkest depths of being in pain 
Yeh 
Then they’re just there and can snap into action whereas the others you  
have to, at least for the moment, this might be because I haven’t done  
them for everyday for eight weeks, so I might find that they take on the  
same qualities as, but those two in particular I can rely on to switch in  
automatically when I start doing them almost without realising, if that  
makes sense? 
  
Outcome-positive 
experience 
Hopes-low 
expectations 
Positive- 
straightforward 
Outcome-reduced 
negative emotions 
Positive- body scan 
Usefulness- when 
pain is bad 
Positive- breathing 
anchor 
Positive- 
straightforward 
Negative- confusing 
Positive- can be 
used in pain 
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Appendix 8: Patient information sheet 
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Appendix 9: Patient consent form 
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